Browse the corpus

Walk the evidence base by book and chapter — the raw source passages that ground Ask, Differential, and the rest.

• "Lost to Follow-up" Among Adult Cancer Survivors.1 passage
• "Pleurex Desalination" in Malignancy-related Ascites: A Novel Mechanism of Hyponatremia.1 passage
• "Was It Worth It?": A Pilot Study in Patient Perspectives on the Worthwhileness of Radiation Therapy.1 passage
• A Limited-Versus-Extensive Staging Strategy for Small Cell Prostate Cancer.1 passage
• A Matter of Comprehensive Informed Consent: Short-Term Mortality Rates With Definitive Treatment Options in Elderly Stage I NSCLC.1 passage
• A Meta-Analysis of the Association Between Radiation Therapy and Survival for Surgically Resected Soft-Tissue Sarcoma.1 passage
• A Model to Predict the Feasibility of Concurrent Chemoradiotherapy With Temozolomide in Glioblastoma Multiforme Patients Over Age 65.1 passage
• A Multicenter Phase II Study of Gemcitabine, Capecitabine, and Bevacizumab for Locally Advanced or Metastatic Biliary Tract Cancer.1 passage
• A Patient-centered Approach to Evaluate the Information Needs of Women With Ductal Carcinoma In Situ.1 passage
• A Phase 1 Study of SLC-0111, a Novel Inhibitor of Carbonic Anhydrase IX, in Patients With Advanced Solid Tumors.1 passage
• A Phase 2 Randomized, Double-Blind, Multicenter Trial of Imexon Plus Gemcitabine Versus Gemcitabine Plus Placebo in Patients With Metastatic Chemotherapy-naïve Pancreatic Adenocarcinoma.1 passage
• A Phase I Clinical Trial of the Phosphatidylserine-targeting Antibody Bavituximab in Combination With Radiation Therapy and Capecitabine in the Preoperative Treatment of Rectal Adenocarcinoma.1 passage
• A Phase I Study of Tomotherapy in Patients With Primary Benign and Low-grade Brain Tumors: Late Toxicity and Quality of Life.1 passage
• A Phase I/II Study of Docetaxel, Oxaliplatin, and Fluorouracil (D-FOX) Chemotherapy in Patients With Untreated Locally Unresectable or Metastatic Adenocarcinoma of the Stomach and Gastroesophageal Junction.1 passage
• A Phase II Study Evaluating Bone Marrow-Sparing, Image-guided Pelvic Intensity-Modulated Radiotherapy (IMRT) With Cesium-131 Brachytherapy Boost, Adjuvant Chemotherapy, and Long-Term Hormonal Ablation in Patients With High Risk, Nonmetastatic Prostate Cancer.1 passage
• A Phase II Study of Biweekly Cisplatin, Fixed-Dose-Rate Gemcitabine and Infusional 5-Fluorouracil in Patients With Metastatic Pancreatic and Biliary Cancers.1 passage
• A Phase II Study of Celecoxib With Irinotecan, 5-Fluorouracil, and Leucovorin in Patients With Previously Untreated Advanced or Metastatic Colorectal Cancer.1 passage
• A Phase II Study of Concurrent Chemoradiotherapy With Paclitaxel and Cisplatin for Inoperable Esophageal Squamous Cell Carcinoma.1 passage
• A Phase II Study of Ganetespib as Second-line or Third-line Therapy for Metastatic Pancreatic Cancer.1 passage
• A Phase II Study of the Combination of Oxaliplatin, Capecitabine, and Trastuzumab and Chemoradiotherapy in the Adjuvant Setting in Operated Patients With HER2-positive Gastric or Gastroesophageal Junction Cancer (TOXAG Study): A Turkish Oncology Group Study.1 passage
• A Phase II Study to Prevent Radiation-induced Rectal Injury With Lovastatin.1 passage
• A Phase Ib Study of the FGFR/VEGFR Inhibitor Dovitinib With Gemcitabine and Capecitabine in Advanced Solid Tumor and Pancreatic Cancer Patients.1 passage
• A Phase1b Dose Escalation Study of Recombinant Circularly Permuted TRAIL in Patients With Relapsed or Refractory Multiple Myeloma.1 passage
• A Pilot Study of Perioperative Cisplatin-Capecitabine Chemotherapy With Preoperative Chemoradiation for Resectable Gastric Cancers.1 passage
• A Pilot Study of Preoperative Vandetanib on Markers of Proliferation and Apoptosis in Breast Cancer.1 passage
• A Pilot Study of Radiation Therapy in Combination With Pembrolizumab in Patients With Metastatic Renal Cell Cancer.1 passage
• A Pilot Study of Short-course Nivolumab and Low-dose Ipilimumab for Adjuvant Treatment of Melanoma: Brown University Oncology Research Group Trial, BrUOG 324.1 passage
• A Pooled Analysis of Biochemical Failure in Intermediate-risk Prostate Cancer Following Definitive Stereotactic Body Radiotherapy (SBRT) or High-Dose-Rate Brachytherapy (HDR-B) Monotherapy.1 passage
• A Population-based Study of Treatment Patterns and Survival of Patients With De Novo Stage IV Non-Small Cell Lung Cancer.1 passage
• A Prospective Evaluation of the Reliability and Utility of Quality of Life Measures in Patients With Hepatocellular Carcinoma.1 passage
• A Prospective Study About Trastuzumab-induced Cardiotoxicity in HER2-positive Breast Cancer.1 passage
• A Retrospective Feasibility Study of Salvage Pelvic Nodal Radiation in 6 Patients With Biochemical Failure Following Prostate Fossa Radiation: An Alternative to Androgen Deprivation Therapy (ADT).1 passage
• A Review of Treatment for Breast Cancer-Related Lymphedema: Paradigms for Clinical Practice.1 passage
• A Review of the Surgical Management of Extrathoracic Solitary Fibrous Tumors.1 passage
• A Simple, Novel Prognostic Score in Platinum Sensitive Relapsed Ovarian Cancer.1 passage
• A Simplified Risk Stratification Method for Women With Stage I Endometrial Carcinoma.1 passage
• A Single-institution Comparison of Cetuximab, Carboplatin, and Paclitaxel Induction Chemotherapy Followed by Chemoradiation (CRT) Versus CRT for Locally Advanced Squamous Cell Carcinoma of the Head and Neck (LA-SCCHN).1 passage
• A comparison between the Chinese 2008 and the 7th edition AJCC staging systems for nasopharyngeal carcinoma.1 passage
• A review of the impact of preoperative chemoradiotherapy on outcome and postoperative complications in esophageal cancer patients.1 passage
• ACR Appropriateness Criteria(®) induction and adjuvant therapy for N2 non-small-cell lung cancer.1 passage
• ACR Appropriateness Criteria® Diffuse Large B-Cell Lymphoma.1 passage
• ACR Appropriateness Criteria® Hodgkin Lymphoma-Favorable Prognosis Stage I and II.1 passage
• ACR Appropriateness Criteria® Hodgkin Lymphoma-Unfavorable Clinical Stage I and II.1 passage
• ACR Appropriateness Criteria® Local Excision in Early Stage Rectal Cancer.1 passage
• ACR Appropriateness Criteria® Locally Advanced, High-Risk Prostate Cancer.1 passage
• ACR Appropriateness Criteria® Management of Recurrent Endometrial Cancer.1 passage
• ACR Appropriateness Criteria® Resectable Pancreatic Cancer.1 passage
• ACR-ACNM-ASTRO-SNMMI Practice Parameter for the Performance of Therapy With Radium-223.1 passage
• ACR-ASTRO Practice Parameter for Communication: Radiation Oncology.1 passage
• ACR-ASTRO Practice Parameter for Image-guided Radiation Therapy (IGRT).1 passage
• ACR-ASTRO Practice Parameter for the Performance of Proton Beam Radiation Therapy.1 passage
• ACR-ASTRO Practice Parameter for the Performance of Stereotactic Body Radiation Therapy.1 passage
• Academic and Resident Radiation Oncologists' Attitudes and Intentions Regarding Radiation Therapy near the End of Life.1 passage
• Accelerated Hypofractionated Radiation Therapy for Elderly Frail Bladder Cancer Patients Unfit for Surgery or Chemotherapy.1 passage
• Accelerated hypofractionated whole-breast irradiation with concomitant daily boost in early breast cancer.1 passage
• Adherence Patterns to National Comprehensive Cancer Network Guidelines for Referral of Women With Breast Cancer to Genetics Professionals.1 passage
• Adjuvant Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors (TKIs) in Resected Non-Small Cell Lung Cancer (NSCLC): A Systematic Review and Meta-analysis.1 passage
• Adjuvant External Radiation Impacts Outcome of Pelvis-limited Stage III Endometrial Carcinoma: A Multi-institutional Study.1 passage
• Adjuvant FOLFOX+Nab-Paclitaxel (FOLFOX-A) for Pancreatic Cancer: A Brown University Oncology Research Group Phase II Study (BrUOG295).1 passage
• Adjuvant Gemcitabine and Gemcitabine-based Chemoradiotherapy Versus Gemcitabine Alone After Pancreatic Cancer Resection: The Indiana University Experience.1 passage
• Adjuvant Pelvic Radiation Therapy±Vaginal Brachytherapy in Patients With High-risk Stage I or Stage II Uterine Papillary Serous, Clear Cell, and High-grade Endometrioid Carcinoma.1 passage
• Adjuvant Radiotherapy Versus Wait-and-See Strategy for Pathologic T3 or Margin-Positive Prostate Cancer: A Meta-Analysis.1 passage
• Adjuvant Radiotherapy for Stages II and III Resected Thymoma: A Single-institutional Experience.1 passage
• Adjuvant Trastuzumab Emtansine (T-DM1) and Concurrent Radiotherapy for Residual Invasive HER2-positive Breast Cancer: Single-center Preliminary Results.1 passage
• Adjuvant chemoradiation plus intraoperative radiotherapy versus adjuvant chemoradiation alone in patients with locally advanced rectal cancer.1 passage
• Adjuvant versus salvage radiation therapy for prostate cancer patients with adverse pathologic features: comparative analysis of long-term outcomes.1 passage
• Advanced Age is Not a Contraindication for Treatment With Curative Intent in Esophageal Cancer.1 passage
• Advances in the management of recurrent endometrial cancer.1 passage
• Age Bias in Time From Diagnosis Comparisons of Prostate Cancer Treatment.1 passage
• Age and genetics: how do prognostic factors at diagnosis explain disparities in acute myeloid leukemia?1 passage
• Albumin and Neutrophil-Lymphocyte Ratio (NLR) Predict Survival in Patients With Pancreatic Adenocarcinoma Treated With SBRT.1 passage
• Alcohol Abuse Decreases Pelvic Control and Survival in Cervical Cancer: An Opportunity of Lifestyle Intervention for Outcome Improvement.1 passage
• All-Cause 30-Day Mortality After Surgical Treatment for Head and Neck Squamous Cell Carcinoma in the United States.1 passage
• Alzheimer Gene BIN1 may Simultaneously Influence Dementia Risk and Androgen Deprivation Therapy Dosage in Prostate Cancer.1 passage
• An Albumin-Bilirubin (ALBI) Grade-based Prognostic Model For Patients With Hepatocellular Carcinoma Within Milan Criteria.1 passage
• An Evaluation of the Eighth Edition of the American Joint Committee on Cancer (AJCC) Staging System for Retroperitoneal Sarcomas Using the National Cancer Data Base (NCDB): Does Size Matter?1 passage
• An Update to Changing Patterns of Anal Carcinoma in the United States.1 passage
• Analysis of Heterogeneity in Survival Benefit of Immunotherapy in Oncology According to Patient Demographics and Performance Status: A Systematic Review and Meta-Analysis of Overall Survival Data.1 passage
• Analysis of Outcomes in Patients With BRCA1/2 Breast Cancer Mutations Treated With Accelerated Partial Breast Irradiation (APBI).1 passage
• Analysis of Prognostic Factors Affecting the Outcome of Stage IB-IIB Cervical Cancer Treated by Radical Hysterectomy and Pelvic Lymphadenectomy.1 passage
• Analysis of the Relationship Between Response to Chemotherapy and Response to Radiation Therapy in Patients With Non-Small Cell Lung Cancer Receiving Sequential Treatment.1 passage
• Analyzing the Time From Discovery to Definitive Surgical Therapy for Lung Cancer Based on Referral Patterns.1 passage
• Anaplastic Lymphoma Kinase (ALK)-positive Tumors: Clinical, Radiographic and Molecular Profiles, and Uncommon Sites of Metastases in Patients With Lung Adenocarcinoma.1 passage
• Angiosarcoma of the Breast: Management and Outcomes.1 passage
• Appendix-derived Pseudomyxoma Peritonei (PMP): Molecular Profiling Toward Treatment of a Rare Malignancy.1 passage
• Application of a Prognostic Stratification System for High-risk Prostate Cancer to Patients Treated With Radiotherapy: Implications for Treatment Optimization.1 passage
• Artificial Intelligence Estimates the Importance of Baseline Factors in Predicting Response to Anti-PD1 in Metastatic Melanoma.1 passage
• Asian Versus Non-Asian Outcomes in Nasopharyngeal Carcinoma: A North American Population-based Analysis.1 passage
• Assessment of False-negative Ascites Cytology in Epithelial Ovarian Carcinoma: A Study of 313 Patients.1 passage
• Assessment of the Albumin-Bilirubin (ALBI) Grade as a Prognostic Indicator for Hepatocellular Carcinoma Patients Treated With Radioembolization.1 passage
• Association Between Metabolic Syndrome and Endometrial Cancer Survival in a SEER-Medicare Linked Database.1 passage
• Association Between Radiation Dose and Outcomes With Postoperative Radiotherapy for N0-N1 Non-Small Cell Lung Cancer.1 passage
• Association Between Smoking and Survival Benefit of Immunotherapy in Advanced Malignancies: A Systematic Review and Meta-Analysis.1 passage
• Association of Diabetes and Other Clinical and Sociodemographic Factors With Guideline-concordant Breast Cancer Treatment for Breast Cancer.1 passage
• Association of Graded Folic Acid Supplementation and Total Plasma Homocysteine Levels With Hematological Toxicity During First-line Treatment of Nonsquamous NSCLC Patients With Pemetrexed-based Chemotherapy.1 passage
• Association of Rurality With Survival and Guidelines-Concordant Management in Early-stage Non-Small Cell Lung Cancer.1 passage
• Association of short duration from initial symptoms to specialist consultation with poor survival in soft-tissue sarcomas.1 passage
• Atypical Lipomatous Tumors: Does Our Inconsistent Terminology Have Patient Repercussions? Results of a Meta-Analysis.1 passage
• Autophagy-related Proteins as a Prognostic Factor of Patients With Colorectal Cancer.1 passage
• Axillary Ultrasound Fine Needle Aspiration Biopsy: Is There a Role in the Post Z-0011 Era?1 passage
• BCLC-B Subclassification and the Hong Kong Liver Cancer System in Intermediate Hepatocellular Carcinoma: Identifying Candidates for Curative Therapy.1 passage
• BRCA1 Mutations Associated With Increased Risk of Brain Metastases in Breast Cancer: A 1: 2 Matched-pair Analysis.1 passage
• Benefit of Radiotherapy in Extraskeletal Myxoid Chondrosarcoma: A Propensity Score Weighted Population-based Analysis of the SEER Database.1 passage
• Benefits of a Multidisciplinary Women's Sexual Health Clinic in the Management of Sexual and Menopausal Symptoms After Pelvic Radiotherapy.1 passage
• Biological Effects of Anti-Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Antibody Formation in Patients Treated With GM-CSF (Sargramostim) as Adjuvant Therapy of Melanoma.1 passage
• Bisphosphonate-loaded Bone Cement as a Local Adjuvant Therapy for Giant Cell Tumor of Bone: A 1 to 12-Year Follow-up Study.1 passage
• Black Patients Experience Highest Rates of Cancer-associated Venous Thromboembolism.1 passage
• Body Composition by Computed Tomography as a Predictor of Toxicity in Patients With Renal Cell Carcinoma Treated With Sunitinib.1 passage
• Brachytherapy-based Accelerated Partial Breast Irradiation Provides Equivalent 10-Year Outcomes to Whole Breast Irradiation: A Matched-Pair Analysis.1 passage
• Brain Metastases From Gynecologic Malignancies: Prevalence and Management.1 passage
• Brain Metastases at Presentation in Patients With Non-Small Cell Lung Cancer.1 passage
• Brain Radiation Induced Extracranial Abscopal Effects in Metastatic Melanoma.1 passage
• Breast Cancer Stage at Diagnosis in a New Jersey Cancer Education and Early Detection Site.1 passage
• Breast Cancer is Common in Women With Ovarian Malignant Mixed Mullerian Tumors.1 passage
• Breast Imaging in Women Previously Irradiated for Hodgkin Lymphoma.1 passage
• Breast conservation therapy utilizing partial breast brachytherapy for early-stage cancer of the breast: a retrospective review from the Saint Luke's Cancer Institute.1 passage
• Breast-conservation Therapy After Neoadjuvant Chemotherapy Does Not Compromise 10-Year Breast Cancer-specific Mortality.1 passage
• CA 19-9 Response: A Surrogate to Predict Survival in Patients With Metastatic Pancreatic Adenocarcinoma.1 passage
• CMF-regimen preferred as first-course chemotherapy for older and sicker women with breast cancer: Findings from a SEER-Medicare-based population study.1 passage
• CNS Hemangiopericytoma: A Systematic Review of 523 Patients.1 passage
• CTLA-4 and PD-1 Pathways: Similarities, Differences, and Implications of Their Inhibition.1 passage
• Cabergoline in the Management of Residual Nonfunctioning Pituitary Adenoma: A Single-Center, Open-Label, 2-Year Randomized Clinical Trial.1 passage
• Can Surgery be Avoided After Preoperative Chemoradiation for Rectal Cancer in the Era of Organ Preservation? Current Review of Literature.1 passage
• Can elderly patients with newly diagnosed glioblastoma be enrolled in radiochemotherapy trials?1 passage
• Cancer Management During the COVID-19 Pandemic in the United States: Results From a National Physician Cross-sectional Survey.1 passage
• Cancer Rates in Adults After Cardiac Interventions: A Preliminary Observational Report.1 passage
• Cancer Survivorship and Models of Survivorship Care: A Review.1 passage
• Capecitabine and Celecoxib as a Promising Therapy for Thymic Neoplasms.1 passage
• Capecitabine, Oxaliplatin, Irinotecan, and Bevacizumab Combination Followed by Pazopanib Plus Capecitabine Maintenance for High-Grade Gastrointestinal Neuroendocrine Carcinomas.1 passage
• Cardiac Monitoring for Thoracic Radiation Therapy: Survey of Practice Patterns in the United States.1 passage
• Cardiac Toxicity in Operable Esophageal Cancer Patients Treated With or Without Chemoradiation.1 passage
• Cardiac magnetic resonance imaging for the assessment of the myocardium after doxorubicin-based chemotherapy.1 passage
• Cardiopulmonary Aerobic Fitness Assessment During Maximal and Submaximal Exercise Testing in Pediatric Oncology Patients After Chemotherapy.1 passage
• Care Delivery in Cancer Patients With Asymptomatic COVID-19 Infection in a Tertiary, Safety-Net Hospital in Houston, Texas.1 passage
• Celecoxib and Myrtol: A Novel Therapy for Recurrent Appendiceal Mucinous Neoplasms With Extensive Peritoneal Dissemination.1 passage
• Challenges and Opportunities for High-grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangement (Double-hit Lymphoma).1 passage
• Challenges in Management of Squamous Cell Carcinoma of the Anus in New England and Across the United States: A Review of the National Cancer Data Base.1 passage
• Challenging the Requirement to Treat the Contralateral Neck in Cases With >4 mm Tumor Thickness in Patients Receiving Postoperative Radiation Therapy for Squamous Cell Carcinoma of the Oral Tongue or Floor of Mouth.2 passages
• Changes in Treatment Patterns and Overall Survival in Patients With Early-Stage Non-Small Cell Lung Cancer in the United States After the Incorporation of Stereotactic Ablative Radiation Therapy: A Population-based Analysis.1 passage
• Characteristics and Growth Rate of Lung Metastases in Patients With Primary Gastrointestinal Malignancies and Lung-dominant Metastatic Disease: A Retrospective Cohort Analysis.1 passage
• Characteristics and Prognostic Analysis of 69 Patients With Pulmonary Sarcomatoid Carcinoma.1 passage
• Characterization of PD-L1 and PD-1 Expression and CD8+ Tumor-infiltrating Lymphocyte in Epstein-Barr Virus-associated Nasopharyngeal Carcinoma.1 passage
• Characterization of a Novel Entity of G3 (High-grade Well-differentiated) Colorectal Neuroendocrine Tumors (NET) in the SEER Database.2 passages
• Characterizing Urban-Rural Differences in Colon Cancer Outcomes: A Population-based Analysis Based on Travel Distance to Cancer Center.1 passage
• Chemoradiation Versus Chemotherapy in Uterine Carcinosarcoma: Patterns of Care and Impact on Overall Survival.1 passage
• Chemoradiation for High-grade Neuroendocrine Carcinoma of the Rectum and Anal Canal.1 passage
• Chemotherapy in Esthesioneuroblastoma/Olfactory Neuroblastoma: An Analysis of the Surveillance Epidemiology and End Results (SEER) 1973-2015 Database.1 passage
• Chemotherapy is of Value in Second Line and Beyond, Relapsed High-grade, Serous Epithelial Ovarian Cancer: An Analysis of Outcomes Obtained With Oral Etoposide.1 passage
• Chemotherapy, Irradiation, and Surgery for Function-preserving Curative Therapy of Primary Extremity Soft Tissue Sarcomas: Initial Treatment With I-MAP and Inhalation GM-CSF During Preoperative Irradiation and Postoperatively.1 passage
• Chronological Age and Risk of Chemotherapy Nonfeasibility: A Real-Life Cohort Study of 153 Stage II or III Colorectal Cancer Patients Given Adjuvant-modified FOLFOX6.1 passage
• Cisplatin+Vinorelbine Treatment of Recurrent or Metastatic Salivary Gland Malignancies (RMSGM): A Final Report on 60 Cases.1 passage
• Clinical Characteristics and Outcomes of Eosinophilic Colitis in Patients With Cancer.1 passage
• Clinical Characteristics of Patients Experiencing Pathologic Complete Response Following Neoadjuvant Therapy for Borderline Resectable/Locally Advanced Pancreatic Adenocarcinoma.1 passage
• Clinical Features of Rituximab-associated Gastrointestinal Toxicities.1 passage
• Clinical Impact of Oral Intake in Second-line or Third-line Chemotherapy for 589 Patients With Advanced Gastric Cancer: A Retrospective Cohort Study.1 passage
• Clinical Impact of Percutaneous Transhepatic Insertion of Metal Biliary Endoprostheses for Palliation of Jaundice and Facilitation of Chemotherapy.1 passage
• Clinical Outcomes After Lung Stereotactic Body Radiation Therapy in Patients With or Without a Prior Lung Resection.1 passage
• Clinical Outcomes Following Stereotactic Body Radiation Therapy (SBRT) for Stage I Medically Inoperable Small Cell Lung Carcinoma: A Multi-Institutional Analysis From the RSSearch Patient Registry.1 passage
• Clinical Outcomes of Metastatic Renal Carcinoma Following Disease Progression to Programmed Death (PD)-1 or PD-L1 Inhibitors (IO): A Meet-URO Group Real World Study (Meet-Uro 7).1 passage
• Clinical Outcomes of Patients With Gastrointestinal Malignancies Participating in Phase I Clinical Trials.1 passage
• Clinical Outcomes of Patients With Unresectable Cholangiocarcinoma Treated With Proton Beam Therapy.1 passage
• Clinical Outcomes of Patients With pT1-T2N0 Oral Tongue Squamous Cell Carcinoma.1 passage
• Clinical Outcomes of Surgically Unresectable Endometrial Cancers.1 passage
• Clinical Significance of ABCG2 Haplotype-tagging Single Nucleotide Polymorphisms in Patients With Unresectable Non-Small Cell Lung Cancer Treated With First-line Platinum-based Chemotherapy.1 passage
• Clinical Significance of Molecular Micrometastasis in the Sentinel Lymph Node of Early-stage Non-Small Cell Lung Cancer Patients.1 passage
• Clinical Uncertainty and Equipoise in the Management of Recurrent Glioblastoma.1 passage
• Clinical Use and Optimal Cutoff Value of Ca15-3 in Evaluation of Adnexal Mass: Retrospective Cohort Study and Review of the Literature.1 passage
• Clinical Utility of a Blood-based Protein Assay on Diagnostic Colonoscopy Referrals for Elevated-risk Colorectal Cancer Patients in Primary Care.1 passage
• Clinical and Demographic Factors Associated With Receipt of Non Guideline-concordant Initial Therapy for Nonmetastatic Prostate Cancer.1 passage
• Clinical and Economic Evaluation of Treatment Strategies for T1N0 Anal Canal Cancer.1 passage
• Clinical and Genetic Factors Associated With Severe Hematological Toxicity in Glioblastoma Patients During Radiation Plus Temozolomide Treatment: A Prospective Study.1 passage
• Clinical and Molecular Recursive Partitioning Analysis of High-grade Glioma Treated With IMRT.1 passage
• Clinical and Prognostic Significance of Coagulation Assays in Pancreatic Cancer Patients With Absence of Venous Thromboembolism.1 passage
• Clinical and Radiographic Outcomes From Repeat Whole-brain Radiation Therapy for Brain Metastases in the Age of Stereotactic Radiosurgery.1 passage
• Clinical, Radiographic, and Pathologic Findings in Patients Undergoing Reoperation Following Radiation Therapy and Temozolomide for Newly Diagnosed Glioblastoma.1 passage
• Clinicopathologic Features and Outcome of Young Adults With Stage IV Colorectal Cancer.1 passage
• Combination Therapy for Metastatic Renal Cell Carcinoma: A Systematic Review and Network Meta-analysis.1 passage
• Combined neoadjuvant chemotherapy with bevacizumab improves pathologic complete response in patients with hormone receptor negative operable or locally advanced breast cancer.1 passage
• Comparing Late-line Treatment Sequence of Regorafenib and Reduced-intensity FOLFOXIRI for Refractory Metastatic Colorectal Cancer.2 passages
• Comparison of Clinical Characteristics and Outcomes in Relapsed Versus De Novo Metastatic Non-Small Cell Lung Cancer.1 passage
• Comparison of Demographics, Tumor Characteristics, and Survival Between Pancreatic Adenocarcinomas and Pancreatic Neuroendocrine Tumors: A Population-based Study.1 passage
• Comparison of FOLFIRINOX and Gemcitabine Plus Nab-paclitaxel for Treatment of Metastatic Pancreatic Cancer: Using Korean Pancreatic Cancer (K-PaC) Registry.1 passage
• Comparison of In-Hospital and Long-term Outcomes of Sublobar Lung Cancer Surgery by VATS and Open Techniques.1 passage
• Comparison of Outcomes in Patients With Muscle-invasive Bladder Cancer Treated With Radical Cystectomy Versus Bladder Preservation.1 passage
• Comparison of Radiation Treatment Volumes for Borderline Resectable Pancreatic Cancer in Contemporary Clinical Trials.1 passage
• Comparison of Toxicity and Treatment Outcomes in HIV-positive Versus HIV-negative Patients With Squamous Cell Carcinoma of the Anal Canal.1 passage
• Competing Mortality in Patients With Neuroendocrine Tumors.1 passage
• Complete Neoadjuvant Treatment for Rectal Cancer: The Brown University Oncology Group CONTRE Study.1 passage
• Concomitant Chemoradiotherapy With Image-guided Pulsed Dose Rate Brachytherapy as a Definitive Treatment Modality for Early-stage Cervical Cancer.1 passage
• Concomitant Use of Proton Pump Inhibitors With Capecitabine Based Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer: Is it Safe?1 passage
• Concurrent Chemoradiotherapy With Cisplatin Versus Cetuximab for Squamous Cell Carcinoma of the Head and Neck.1 passage
• Concurrent Chemoradiotherapy in the Adjuvant Treatment of High-risk Primary Salivary Gland Malignancies.1 passage
• Concurrent Nab-paclitaxel and Radiotherapy: Novel Radiosensitization for Borderline Resectable or Unresectable Pancreatic Cancer.1 passage
• Concurrent Radiation and Immunotherapy: Survey of Practice Patterns in the United States.1 passage
• Concurrent Radiosurgery and Immune Checkpoint Inhibition: Improving Regional Intracranial Control for Patients With Metastatic Melanoma.1 passage
• Concurrent Radiotherapy With Cetuximab or Platinum-based Chemotherapy for Locally Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck.1 passage
• Concurrent Radiotherapy and Triweekly Carboplatin for the Definitive Treatment of Locally Advanced Laryngeal Carcinoma.1 passage
• Concurrent Versus Sequential Chemoradiation for Low-grade Gliomas Meeting RTOG 9802 Criteria.1 passage
• Concurrent involved-field radiotherapy and XELOX versus XELOX chemotherapy alone in gastric cancer patients with postoperative locoregional recurrence.1 passage
• Concurrent β-blocker Use is Associated With Improved Outcome in Esophageal Cancer Patients Who Undergo Chemoradiation: A Retrospective Matched-pair Analysis.1 passage
• Conditional Survival Analysis of Metastatic Colorectal Cancer Patients Living ≥24 Months: A Single Institutional Study.1 passage
• Contemporary Patterns and Survival Outcome of Adjuvant Systemic Therapy for Localized Gastrointestinal Stromal Tumors.1 passage
• Contribution of involved-field radiotherapy to survival in patients with relapsed or refractory Hodgkin lymphoma undergoing autologous stem cell transplantation.1 passage
• Correlation Between Standardized Uptake Value in Preneoadjuvant and Postneoadjuvant Chemoradiotherapy and Tumor Regression Grade in Patients With Locally Advanced Esophageal Cancer.1 passage
• Cost-Effectiveness Analysis of Upfront SBRT for Oligometastatic Stage IV Non-Small Cell Lung Cancer Based on Mutational Status.1 passage
• Cost-Effectiveness of Cetuximab as First-line Treatment for Metastatic Colorectal Cancer in the United States.1 passage
• Cost-effectiveness Analysis of Ado-trastuzumab Emtansine (T-DM1) for the Adjuvant Treatment of Patients With Residual Invasive HER2+ Early Breast Cancer in the United States.1 passage
• Cost-effectiveness of Management Options for Small Renal Mass: A Systematic Review.1 passage
• Curative Intent Radiotherapy Delivered Within the Last Year of Life.1 passage
• Curative-dose Chemoradiotherapy Versus Total Laryngectomy For Stage T3-T4 Squamous Cell Carcinoma of the Larynx: An "Apples-to-Apples" Analysis of the National Cancer Database.1 passage
• Current Status of Chimeric Antigen Receptor T-Cell Therapy in Multiple Myeloma.1 passage
• Decision making and factors influencing long-term satisfaction with prophylactic mastectomy in women with breast cancer.1 passage
• Decreased Risk of Radiation Pneumonitis With Coincident Concurrent Use of Angiotensin-converting Enzyme Inhibitors in Patients Receiving Lung Stereotactic Body Radiation Therapy.1 passage
• Defining Eligibility of FOLFIRINOX for First-Line Metastatic Pancreatic Adenocarcinoma (MPC) in the Province of British Columbia: A Population-based Retrospective Study.1 passage
• Definitive Chemoradiation With Full-dose Gemcitabine for Unresectable Pancreatic Cancer: Efficacy of Involved-Field Radiotherapy.1 passage
• Definitive Chemoradiation for Squamous Cell Carcinoma of the Rectum.1 passage
• Definitive Chemoradiotherapy Results in Synchronous Oligometastatic Non-small Cell Lung Cancer Patients: Turkish Society for Radiation Oncology Group Study (TROD 10-003).1 passage
• Definitive Local Therapy for Oligo-recurrence in Patients With Completely Resected Non-small Cell Lung Cancer.1 passage
• Definitive Radiation Therapy for Stage I-II Endometrial Cancer: An Observational Study of Nonoperative Management.1 passage
• Definitive Radiation Treatment Patterns and Outcomes for Low and Intermediate Risk Prostate Cancer Patients: A Cross-Continental Comparative Study.1 passage
• Definitive Stereotactic Body Radiotherapy (SBRT) for Extracranial Oligometastases: An International Survey of >1000 Radiation Oncologists.1 passage
• Dermal Lymphatic Invasion, Survival, and Time to Recurrence or Progression in Inflammatory Breast Cancer.1 passage
• Determining Optimal Follow-up for Patients With Anal Cancer Following Chemoradiation.1 passage
• Determining the Impact of a Cancer Diagnosis on Diabetes Management: A Systematic Literature Review.1 passage
• Development and Validation of an Individualized Nomogram for Predicting Overall Survival in Patients With Typical Lung Carcinoid Tumors.1 passage
• Development of an Integer-based Risk Score to Predict 90-Day Mortality After Hepatectomy in Patients With Hepatocellular Carcinoma.1 passage
• Diagnosis of Axillary Web Syndrome in Patients After Breast Cancer Surgery: Epidemiology, Risk Factors, and Clinical Aspects: A Prospective Study.1 passage
• Diagnosis of EML4-ALK Translocation With FISH, Immunohistochemistry, and Real-time Polymerase Chain Reaction in Patients With Non-Small Cell Lung Cancer.1 passage
• Diagnostic Performance of Initial Transperineal Template-guided Mapping Biopsy of the Prostate Gland.1 passage
• Diagnostic Test Accuracy of Glasgow Prognostic Score as a Prognostic Factor for Renal Cell Carcinoma: A Meta-Analysis.1 passage
• Diagnostic Values of 8 Different Imaging Modalities for Preoperative Detection of Axillary Lymph Node Metastasis of Breast Cancer: A Bayesian Network Meta-analysis.1 passage
• Differences in Funding Sources of Phase III Oncology Clinical Trials by Treatment Modality and Cancer Type.1 passage
• Differential Efficacy of Anti-VEGF Antibodies Based on Sex and Race in a Diverse Cohort of Advanced Nonsquamous Non-Small Cell Lung Cancer.1 passage
• Differential Outcomes Among Immunosuppressed Patients With Merkel Cell Carcinoma: Impact of Immunosuppression Type on Cancer-specific and Overall Survival.1 passage
• Differential Prognostic Impact of Strong PD-L1 Expression and 18F-FDG Uptake in Triple-negative Breast Cancer.1 passage
• Direct percutaneous transhepatic portomesenteric venous stenting in management of locally advanced pancreatic cancer.1 passage
• Discord Among Radiation Oncologists and Urologists in the Postoperative Management of High-Risk Prostate Cancer.1 passage
• Disparities Predict for Higher Rates of Cut-through Hysterectomies in Locally Advanced Cervical Cancer.1 passage
• Disparities in Surgical Recommendation for Stage I Non-Small Cell Lung Cancer.1 passage
• Disparities in the Use of Adjuvant External Beam Radiation Therapy in Node-positive Cervical Cancer Patients Following Hysterectomy.1 passage
• Disparity in Outcomes for Adolescent and Young Adult Patients Diagnosed With Pediatric Solid Tumors Across 4 Decades.1 passage
• Do Patients With Multiple Myeloma Enrolled in Clinical Trials Live Longer?1 passage
• Do Prostate Cancer Patients With Markedly Elevated PSA Benefit From Radiation Therapy?: A Population-based Study.1 passage
• Do Sociodemographic Factors Influence Outcome in Prostate Cancer Patients Treated With External Beam Radiation Therapy?1 passage
• Does Choline PET/CT Change the Management of Prostate Cancer Patients With Biochemical Failure?1 passage
• Does Delaying Surgical Resection After Neoadjuvant Chemoradiation Impact Clinical Outcomes in Locally Advanced Rectal Adenocarcinoma?: A Single-Institution Experience.1 passage
• Does Early Chemotherapy Improve Survival in Advanced Endometrial Cancer?1 passage
• Does Race Influence Health-related Quality of Life and Toxicity Following Proton Therapy for Prostate Cancer?1 passage
• Does Specialty Bias Trump Evidence in the Management of High-risk Prostate Cancer?1 passage
• Does the Interval Between Hysterectomy and Start of Adjuvant Radiation Treatment Influence Survival in Women With Endometrial Carcinoma?: A National Cancer Database analysis.1 passage
• Dose Escalation Study of Concurrent Chemoradiotherapy With the Use of Involved-field Conformal Radiotherapy and Accelerated Hyperfractionation in Combination With Cisplatin and Vinorelbine Chemotherapy for Stage III Non-small Cell Lung Cancer: The Final Report.1 passage
• Dose Escalation in Stereotactic Body Radiation Therapy for Pancreatic Cancer: A Meta-Analysis.1 passage
• Dose-Escalation Study of Thoracic Radiotherapy in Combination With Pemetrexed Plus Cisplatin in Japanese Patients With Locally Advanced Nonsquamous Non-Small Cell Lung Cancer: A Post Hoc Analysis of Survival and Recurrent Sites.1 passage
• Dose-Response Relationships for Meningioma Radiosurgery.1 passage
• Dose-Volume Predictors of Esophagitis After Thoracic Stereotactic Body Radiation Therapy.1 passage
• Dose-escalated Hypofractionated Intensity-modulated Radiation Therapy With Concurrent Chemotherapy for Inoperable or Unresectable Non-Small Cell Lung Cancer.1 passage
• Dosimetric Correlate of Cardiac-Specific Survival Among Patients Undergoing Coronary Artery Stenting After Thoracic Radiotherapy for Cancer.1 passage
• Dosimetric definitions of total lung volumes in calculating parameters predictive for radiation-induced pneumonitis.1 passage
• Doxorubicin and Olaratumab Versus Doxorubicin, Ifosfamide, and Mesna for Treatment of Advanced Soft Tissue Sarcomas.1 passage
• Dual Modality Radiation With External Beam Radiation Therapy and Transarterial Radioembolization for Hepatocellular Carcinoma With Gross Vascular Invasion.1 passage
• Ductal Carcinoma In Situ of the Breast: Evaluating the Role of Radiation Therapy in the Management and Attempts to Identify Low-risk Patients.1 passage
• Dynamic Angiogenic Switch as Predictor of Response to Chemotherapy-Bevacizumab in Patients With Metastatic Colorectal Cancer.1 passage
• EGFR Exon 19 Deletion is Associated With Favorable Overall Survival After First-line Gefitinib Therapy in Advanced Non-Small Cell Lung Cancer Patients.1 passage
• ENvironmental Dynamics Underlying Responsive Extreme Survivors (ENDURES) of Glioblastoma: A Multidisciplinary Team-based, Multifactorial Analytical Approach.1 passage
• Early Exploratory Analysis for Patient-reported Quality of Life and Dosimetric Correlates in Hypofractionated Stereotactic Body Radiation Therapy (SBRT) for Low-risk and Intermediate-risk Prostate Cancer: Interim Results from a Prospective Phase II Clinical Trial.1 passage
• Early Impact of the Affordable Care Act and Medicaid Expansion on Racial and Socioeconomic Disparities in Cancer Care.1 passage
• Early Palliative Care Is Associated With Reduced Emergency Department Utilization in Pancreatic Cancer.1 passage
• Early Results From the Implementation of a Lung Cancer Screening Program: The Beaumont Health System Experience.1 passage
• Early, Prophylactic Thyroidectomy in Hereditary Medullary Thyroid Carcinoma: A 26-year Monoinstitutional Experience.1 passage
• Early-stage Uterine Pure and Mixed Clear Cell Carcinoma: Outcomes and Recurrence With and Without Adjuvant Therapy.1 passage
• Effect of Age on Cancer-specific Mortality in Patients With Urothelial Carcinoma of the Urinary Bladder: A Population-based Competing-risks Analysis Across Disease Stages.1 passage
• Effect of Mismatch Repair Status on Outcome of Early-Stage Grade 1 to 2 Endometrial Cancer Treated With Vaginal Brachytherapy.1 passage
• Effect of Neutropenic Diet on Infection Rates in Cancer Patients With Neutropenia: A Meta-analysis of Randomized Controlled Trials.1 passage
• Effect of Surgical Intervention on Survival of Patients With Clinical N2 Non-Small Cell Lung Cancer: A Veterans' Affairs Central Cancer Registry (VACCR) Database Analysis.1 passage
• Effectiveness and Safety of Reirradiation With Stereotactic Ablative Radiotherapy of Lung Cancer After a First Course of Thoracic Radiation: A Meta-analysis.1 passage
• Effects of Adjuvant Radiotherapy in Patients With Synovial Sarcoma.1 passage
• Effects of Chemotherapy Regimen and Radiation Modality on Hematologic Toxicities in Patients Receiving Definitive Platinum-based Doublet Chemoradiation for Non-Small Cell Lung Cancer.1 passage
• Effects of Social and Contextual Factors Including Marital Status and Children on the Use of Palliative Chemotherapy in Metastatic Colorectal Cancer.1 passage
• Efficacy and Safety of Gefitinib as Third-line Treatment in NSCLC Patients With Activating EGFR Mutations Treated With First-line Gefitinib Followed by Second-line Chemotherapy: A Single-Arm, Prospective, Multicenter Phase II Study (RE-CHALLENGE, CTONG1304).1 passage
• Efficacy and Safety of Gemcitabine Plus Cisplatin as Potential Preoperative Chemotherapy in Locally Advanced Intrahepatic, Perihilar, and Mid-Cholangiocarcinoma: A Retrospective Cohort Study.1 passage
• Efficacy and Tolerability of Palliative Split-Course Thoracic Chemoradiotherapy for Symptomatic Non-Small Cell Lung Cancer.1 passage
• Efficacy and Toxicity of Every 2 Weeks Docetaxel Regimen in Comparison With Weekly or Every 3 Weeks in Metastatic Prostate Cancer: A Retrospective Analysis.1 passage
• Efficacy of Low-dose and High-dose Radioactive Iodine Ablation With rhTSH in Korean Patients With Differentiated Thyroid Carcinoma: The First Report in Nonwestern Countries.1 passage
• Efficacy of Modified Dose-dense Paclitaxel in Recurrent Cervical Cancer.1 passage
• Efficacy of oxaliplatin-based chemotherapy + bevacizumab as first-line treatment for advanced colorectal cancer: a systematic review and pooled analysis of published trials.1 passage
• Efficacy of rechallenge chemotherapy in patients with sensitive relapsed small cell lung cancer.1 passage
• Efficacy, Safety, and Potential Biomarkers of Sunitinib and Transarterial Chemoembolization (TACE) Combination in Advanced Hepatocellular Carcinoma (HCC): Phase II Trial.1 passage
• Elevated Pretreatment CEA and CA19-9 Levels are Related to Early Treatment Failure in Esophageal Adenocarcinoma.1 passage
• Eligibility Criteria and Endpoints in Metastatic Renal Cell Carcinoma Trials.1 passage
• Eligibility for Second-line Therapy in Patients With Advanced Hepatocellular Carcinoma: A Population-based Study.1 passage
• Eligibility of Metastatic Pancreatic Cancer Patients for First-Line Palliative Intent nab-Paclitaxel Plus Gemcitabine Versus FOLFIRINOX.1 passage
• Emerging immunotherapies in the treatment of non-small cell lung cancer (NSCLC): the role of immune checkpoint inhibitors.1 passage
• Emerging therapies in multiple myeloma.1 passage
• Emphasis on Systemic Therapy in Women With Pelvic Bone Metastasis at Time of Diagnosis of Cervical Cancer.1 passage
• Endometrial Cancer, BRCA1, and BRCA2 in the UK Biobank Cohort.1 passage
• Epidemiology, Tumor Characteristics, and Survival in Patients With Primary Pancreatic Lymphoma: A Large Population-based Study Using the SEER Database.1 passage
• Eribulin Mesylate for the Treatment of Metastatic Hormone-refractory and Triple-negative Breast Cancer: A Multi-institutional Real-world Report on Efficacy and Safety.1 passage
• Erlotinib Salvage Therapy in Pulmonary Adenocarcinoma Patients With Disease Progression After Previous EGFR-TKI Treatment.1 passage
• Esthesioneuroblastoma of the nasal cavity.1 passage
• Etoposide, Methotrexate, and Dactinomycin Alternating With Cyclophosphamide and Vincristine (EMACO) for Male Patients With HCG-expressing, Chemoresistant Germ Cell Tumors.1 passage
• Evaluating Candidacy for Hypofractionated Radiation Therapy, Accelerated Partial Breast Irradiation, and Endocrine Therapy After Breast Conserving Surgery: A Surveillance Epidemiology and End Results (SEER) Analysis.1 passage
• Evaluating the Role of Interdigitated Neoadjuvant Chemotherapy and Radiation in the Management of High-Grade Soft-Tissue Sarcoma: The Johns Hopkins Experience.1 passage
• Evaluation of Clinical and Pathologic Risk Factors May Reduce the Rate of Multimodality Treatment of Early Cervical Cancer.1 passage
• Evaluation of Genetic Variants in MIR3142HG in Susceptibility to and Prognosis of Glioma.1 passage
• Evaluation of Outcomes in Patients With Carcinoma of the Cervix Treated With Concurrent Radiation and Cisplatin Versus Cisplatin/5-FU Compared With Radiation Alone.1 passage
• Exceptional Responders in Oncology: A Systematic Review and Meta-Analysis of Patient Level Data.1 passage
• Exercise Protocol With Limited Shoulder Range of Motion for 15 or 30 Days After Conservative Surgery for Breast Cancer With Oncoplastic Technique: A Randomized Clinical Trial.1 passage
• Expanding the Spectrum of Radiation Necrosis After Stereotactic Radiosurgery (SRS) for Intracranial Metastases From Lung Cancer: A Retrospective Review.1 passage
• Expansion of the LabBM Score: Is the LabPS the Best Tool Predicting Survival in Patients With Brain Metastases?1 passage
• Extracranial Abscopal Effects Induced by Brain Radiation in Advanced Lung Cancer.1 passage
• Extraskeletal Myxoid Chondrosarcomas: Combined Modality Therapy With Both Radiation and Surgery Improves Local Control.1 passage
• Extraskeletal Osteosarcoma: An International Rare Cancer Network Study.1 passage
• Extraskeletal Osteosarcoma: Outcomes and the Role of Chemotherapy.1 passage
• Extraskeletal Osteosarcomas: A Case Made for Combined Modality Local Therapy With Radiation and Surgery.1 passage
• FOLFOX+Nab-Paclitaxel (FOLFOX-A) for Advanced Pancreatic Cancer: A Brown University Oncology Research Group Phase I Study.1 passage
• Factors Affecting Racial Disparities in End-of-Life Care Costs Among Lung Cancer Patients: A SEER-Medicare-based Study.1 passage
• Factors Associated With Acute and Chronic Wound Complications in Patients With Soft Tissue Sarcoma With Long-term Follow-up.1 passage
• Factors Associated With Guideline-recommended KRAS Testing in Colorectal Cancer Patients: A Population-based Study.1 passage
• Factors Associated With Head and Neck Cancer Hospitalization Cost and Length of Stay-A National Study.1 passage
• Factors Associated With Receipt of Radiation Therapy for Rectal Cancer.1 passage
• Factors Influencing Clinical and Setting Pathways After Discharge From an Acute Palliative/Supportive Care Unit.1 passage
• Factors Predictive of Improved Outcomes With Multimodality Local Therapy After Palliative Chemotherapy for Stage IV Esophageal Cancer.1 passage
• False-positive 1p/19q Testing Results in Gliomas: Clinical and Research Consequences.1 passage
• Fast neutron radiotherapy in the treatment of malignant pleural mesothelioma.1 passage
• Favorable Outcome of Hurthle Cell Carcinoma of the Thyroid Treated With Total Thyroidectomy, Radioiodine, and Selective Use of External-Beam Radiotherapy.1 passage
• Feasibility and Outcome of Routine Use of Concurrent Chemoradiation in HIV-positive Patients With Squamous Cell Anal Cancer.1 passage
• Fertility Preservation Decisions Among Newly Diagnosed Oncology Patients: A Single-Center Experience.1 passage
• Fertility Preservation Services for Women With Newly Diagnosed Cancer: A National Assessment.1 passage
• First-Line Treatment With Atezolizumab Plus Nab-Paclitaxel for Advanced Triple-Negative Breast Cancer: A Cost-Effectiveness Analysis.1 passage
• Food Intake During Cancer Therapy: A Systematic Review.1 passage
• Fractionated Radiation Therapy for Benign Nonacoustic Schwannomas.1 passage
• Fractionated stereotactic radiosurgery for large brain metastases.1 passage
• Function Preservation After Conservative Resection and Radiotherapy for Soft-tissue Sarcoma of the Distal Extremity: Utility and Application of the Toronto Extremity Salvage Score (TESS).1 passage
• Gastrointestinal Adverse Events Observed After Chimeric Antigen Receptor T-Cell Therapy.1 passage
• Gemcitabine Adjuvant Therapy for Resected Pancreatic Cancer: A Meta-analysis.1 passage
• Gemcitabine Plus Cisplatin Chemotherapy Prolongs the Survival in Advanced Hilar Cholangiocarcinoma: A Large Multicenter Study.1 passage
• Gender Differences in Outcomes of Patients With Mesothelioma.1 passage
• Gene Expression Profiling of Tumors From Heavily Pretreated Patients With Metastatic Cancer for the Selection of Therapy: A Pilot Study.1 passage
• Gene expression profiling for early-stage NSCLC.1 passage
• Genomic and Molecular Abnormalities in Gynecologic Clear Cell Carcinoma.1 passage
• Geographic and Patient Characteristics Associated With Election of Prophylactic Mastectomy in Young Breast Cancer Patients With Early Disease.1 passage
• Hematologic Toxicity of Concurrent Administration of Radium-223 and Next-generation Antiandrogen Therapies.1 passage
• Hemorrhagic radiation cystitis.1 passage
• Hepatic Progression-free and Overall Survival After Regional Therapy to the Liver for Metastatic Melanoma.1 passage
• Hepatocellular Carcinoma Management in Nonalcoholic Fatty Liver Disease Patients: Applicability of the BCLC Staging System.1 passage
• Hepatocellular carcinoma: can circulating tumor cells and radiogenomics deliver personalized care?1 passage
• Hepatotoxicity After Immune Checkpoint Inhibitor Therapy in Melanoma: Natural Progression and Management.1 passage
• Heterogenous Dose-escalated Prostate Stereotactic Body Radiation Therapy for All Risk Prostate Cancer: Quality of Life and Clinical Outcomes of an Institutional Pilot Study.1 passage
• High-circulating Tie2 Is Associated With Pathologic Complete Response to Chemotherapy and Antiangiogenic Therapy in Breast Cancer.1 passage
• High-dose Chemotherapy in Germ Cell Cancer Patients With Brain Metastases: Experience of an Expert Center.1 passage
• High-risk Prostate Cancer Treated With Dose-escalated RT: An Analysis of Hormonal Therapy Use and Duration, and Prognostic Implications of PSA Nadir ≤0.2 to Select Men for Short-term Hormonal Therapy.1 passage
• Hospital Case Volume Is Associated With Improved Survival for Patients With Metastatic Melanoma.1 passage
• Hospitalization for Toxicity in Patients Treated With Rituximab.1 passage
• How to Optimize Cancer Treatment in Older Patients: An Overview of Available Geriatric Tools.1 passage
• Hyperfractionated Accelerated Reirradiation for Patients With Recurrent Anal Cancer Previously Treated With Definitive Chemoradiation.1 passage
• Hypoalbuminemia is a Predictive Factor for Fistula Formation in Recurrent Cervical Cancer.1 passage
• Hypofractionated Versus Standard Fractionated Proton-beam Therapy for Low-risk Prostate Cancer: Interim Results of a Randomized Trial PCG GU 002.1 passage
• Identification of Adenosquamous Carcinoma as a Rare Aggressive HER2-negative Subgroup of Esophageal/Gastroesophageal Junction Adenocarcinoma.1 passage
• Identifying Clinical Factors Which Predict for Early Failure Patterns Following Resection for Pancreatic Adenocarcinoma in Patients Who Received Adjuvant Chemotherapy Without Chemoradiation.1 passage
• Immune Checkpoint Inhibitor Nivolumab and Radiotherapy in Pretreated Lung Cancer Patients: Efficacy and Safety of Combination.1 passage
• Immune-priming of the tumor microenvironment by radiotherapy: rationale for combination with immunotherapy to improve anticancer efficacy.1 passage
• Immunogenicity of Influenza Vaccination in Patients With Cancer.1 passage
• Impact of Androgen Deprivation Therapy on Overall Mortality in Prostate Brachytherapy Patients With Low Pretreatment Testosterone Levels.1 passage
• Impact of Brachytherapy Boost and Dose-escalated External Beam Radiotherapy in Margin Positive Cervical Cancer Treated With Chemotherapy and Radiation.1 passage
• Impact of Concomitant Urologic Intervention on Clinical Outcomes After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.1 passage
• Impact of Concurrent Medication Use on Pancreatic Cancer Survival-SEER-Medicare Analysis.1 passage
• Impact of Genetic Mutations and Health Plan Access to Therapies on Treatment Response and Drug Costs Related to Tyrosine Kinase Inhibitor Treatment Among Patients With Chronic Myelogenous Leukemia.1 passage
• Impact of Health Insurance Status on Prostate Cancer Treatment Modality Selection in the United States.1 passage
• Impact of Pain, Opioids, and the Mu-opioid Receptor on Progression and Survival in Patients With Newly Diagnosed Stage IV Pancreatic Cancer.1 passage
• Impact of Postoperative Adjuvant Chemotherapy Following Long-course Chemoradiotherapy in Stage II Rectal Cancer.1 passage
• Impact of Primary Care Access on Mortality of Lung Cancer Patients in an Underserved Community.1 passage
• Impact of Radiation Therapy Dose Escalation on Prostate Cancer Outcomes and Toxicities.1 passage
• Impact of Radiation on Cardiovascular Outcomes in Older Resectable Esophageal Cancer Patients With Medicare.1 passage
• Impact of Right-sided Primary Tumor Location Among Patients With Oligometastatic Colorectal Cancer Treated With Stereotactic Body Radiotherapy.1 passage
• Impact of Sarcopenia, BMI, and Inflammatory Biomarkers on Survival in Advanced Hepatocellular Carcinoma Treated With Anti-PD-1 Antibody.1 passage
• Impact of Staging With Positron-emission Tomography (PET) and Comorbidities on Management and Survival of American Veterans With Stage I-III Non-Small Cell Lung Cancer.1 passage
• Impact of Surgeon Type and Rurality on Treatment and Survival of Ovarian Cancer Patients.1 passage
• Impact of Trabectedin Interruption and Subsequent Rechallenge on Progression in Patients With Advanced Soft Tissue Sarcoma: Long-term Follow-up of the T-DIS trial.1 passage
• Impact of United States Preventive Services Task Force Recommendations on Utilization of Prostate-specific Antigen Screening in Medicare Beneficiaries.1 passage
• Impact of Use of Antibiotics on Response to Immune Checkpoint Inhibitors and Tumor Microenvironment.1 passage
• Impact of Widespread Cervical Cancer Screening: Number of Cancers Prevented and Changes in Race-specific Incidence.1 passage
• Impact of p53, HIF1a, Ki-67, CA-9, and GLUT1 Expression on Treatment Outcomes in Locally Advanced Cervical Cancer Patients Treated With Definitive Chemoradiation Therapy.1 passage
• Impact of radiographic findings on for prognosis skin cancer with perineural invasion.1 passage
• Impact of the Primary Information Source Used for Decision Making on Treatment Perceptions and Regret in Prostate Cancer.1 passage
• Improving Patient-reported Pain During Radiotherapy Through Nurse Involvement and Patient Education.1 passage
• Improving Survival in Patients Treated for a Lung Cancer Using Self-Evaluated Symptoms Reported Through a Web Application.1 passage
• In Reply: Comparing Late-line Treatment Sequence of Regorafenib and Reduced-intensity FOLFOXIRI for Refractory Metastatic Colorectal Cancer.1 passage
• Incidence and Survival of Appendiceal Mucinous Neoplasms: A SEER Analysis.1 passage
• Incidence of Neonatal Neutropenia and Leukopenia After In Utero Exposure to Chemotherapy for Maternal Cancer.1 passage
• Incidence of Severe Nephrotoxicity With Cisplatin Based on Renal Function Eligibility Criteria: Indirect Comparison Meta-analysis.1 passage
• Incidental Coronary Artery Calcium on Breast Radiation Therapy Planning Scans Identifies Patients for Cardiac Preventive Therapy.1 passage
• Increased Resident Diversity Precedes Increased Faculty Diversity: Data From a University Radiation Oncology Department.1 passage
• Increased Risk of Acute Myelogenous Leukemia After Early Onset but Not Late-Onset Colorectal Cancer.1 passage
• Induction Chemotherapy Followed by Concurrent Full-dose Gemcitabine and Intensity-modulated Radiation Therapy for Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma.1 passage
• Induction Therapies Plus Surgery Versus Exclusive Radiochemotherapy in Stage IIIA/N2 Non-Small Cell Lung Cancer (NSCLC).1 passage
• Induction Therapy for Locally Advanced, Resectable Esophagogastric Cancer: A Phase I Trial of Vandetanib (ZD6474), Paclitaxel, Carboplatin, 5-Fluorouracil, and Radiotherapy Followed by Resection.1 passage
• Influence of Comorbidity on the Risk of Death: A Single Institution Study of 1132 Women With Early-stage Uterine Cancer.1 passage
• Influence of Extent of Lymph Node Evaluation on Survival for Pathologically Lymph Node Negative Non-Small Cell Lung Cancer.1 passage
• Influence of NSAID Use Among Colorectal Cancer Survivors on Cancer Outcomes.1 passage
• Inpatient Palliative Care Use Among Critically III Brain Metastasis Patients in the United States.1 passage
• Intensity-modulated Radiation Therapy for Anal Cancer: Results From a Multi-Institutional Retrospective Cohort Study.1 passage
• Interaction Between Primary Tumor Resection, Primary Tumor Location, and Survival in Synchronous Metastatic Colorectal Cancer: A Population-Based Study.1 passage
• Interaction of Salicylates and the Other Nonsteroidal Anti-Inflammatory Agents With Breast Cancer Endocrine Treatment: Systematic Review.1 passage
• Intercostobrachial Nerve (ICBN) Preservation Versus Sacrifice in Axillary Dissection: Randomized Controlled Trial.1 passage
• Interventions to Improve Adherence to Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: A Systematic Review.1 passage
• Intraoperative Radiation Therapy in the Management of Gynecologic Malignancies.1 passage
• Intraoperative Radiotherapy in the Era of Intensive Neoadjuvant Chemotherapy and Chemoradiotherapy for Pancreatic Adenocarcinoma.1 passage
• Intrapatient Molecular and Histologic Heterogeneity After First-generation or Second-generation TKI Therapy of NSCLC Patients: Potential Clinical Impact on Subsequent third-generation TKI Treatment.1 passage
• Intratumoral Vascular Shunting: Biomarker of Clinical Outcome and Source of Circulating Tumor Cells?1 passage
• Ipilimumab and Stereotactic Radiosurgery Versus Stereotactic Radiosurgery Alone for Newly Diagnosed Melanoma Brain Metastases.1 passage
• Irreversible Electroporation (IRE) Combined With Chemotherapy Increases Survival in Locally Advanced Pancreatic Cancer (LAPC).1 passage
• Is Hormone Replacement Therapy Safe in Women With a BRCA Mutation?: A Systematic Review of the Contemporary Literature.1 passage
• Is Surgery-first Still a Reasonable Option in the Era of Neoadjuvant Chemotherapy for Resectable Pancreatic Cancer?1 passage
• Is There a Role for Perioperative Pelvic Radiotherapy in Surgically Resected Stage IV Rectal Cancer?: A Propensity Score-matched Analysis.1 passage
• Is Ultra Hypofractionated Radiation Therapy a Safe and Effective Treatment for Invasive Bladder Cancer in the Elderly?: A Retrospective Single Institution Review.1 passage
• Isolating the Role of Bevacizumab in Elderly Patients With Previously Untreated Nonsquamous Non-Small Cell Lung Cancer: Secondary Analyses of the ECOG 4599 and PointBreak Trials.1 passage
• Journey to Diversity in a University Radiation Oncology Residency Program: The Role of Leadership and Target Goals.1 passage
• KRAS mutation as the biomarker of response to chemotherapy and EGFR-TKIs in patients with advanced non-small cell lung cancer: clues for its potential use in second-line therapy decision making.1 passage
• Knowledge of Clinical Trial Availability and Reasons for Nonparticipation Among Adolescent and Young Adult Cancer Patients: A Population-based Study.1 passage
• Laparoscopic Assessment to Determine the Likelihood of Achieving Optimal Cytoreduction in Patients Undergoing Primary Debulking Surgery for Ovarian, Fallopian Tube, or Primary Peritoneal Cancer.1 passage
• Laparoscopic-assisted Versus Open D2 Gastrectomy for Advanced Gastric Cancer in Highly Selective Patients: Short-term Surgical and Chemotherapy Outcomes of a Prospective Cohort Study.1 passage
• Late Effects After Radiotherapy for Childhood Low-grade Glioma.1 passage
• Late Toxicity and Outcomes in High-risk Prostate Cancer Patients Treated With Hypofractionated IMRT and Long-term Androgen Suppression Treatment.1 passage
• Lenalidomide for second-line treatment of advanced hepatocellular cancer: a Brown University oncology group phase II study.1 passage
• Limitations of the Cancer of the Prostate Risk Assessment (CAPRA) Prognostic Tool for Prediction of Metastases and Prostate Cancer-specific Mortality in Patients Treated With External Beam Radiation Therapy.1 passage
• Lingual Tonsillectomy Likely Does Not Improve Outcomes for Squamous Cell Carcinoma of the Head and Neck From an Unknown Primary Site.1 passage
• Literature Review of Spinal Cord Glioblastoma.1 passage
• Local Control and Use of External Beam Parametrial Boost in the Era of Image-Guided Brachytherapy for Locally Advanced Cervical Cancer.1 passage
• Local Recurrence Outcomes of Colorectal Cancer Oligometastases Treated With Stereotactic Ablative Radiotherapy.1 passage
• Locally Advanced Cervical Cancer: Outcomes With Variable Adherence to Treatment.1 passage
• Locally Advanced Malignant Myoepithelioma of the Parotid Gland Treated With Radiotherapy: A Case Study and Review of the BC Cancer Agency Experience.1 passage
• Location and Grade of Prostate Cancer Diagnosed by Transperineal Template-guided Mapping Biopsy After Negative Transrectal Ultrasound-guided Biopsy.1 passage
• Locoregional Therapy Protocols With and Without Radioembolization for Hepatocellular Carcinoma as Bridge to Liver Transplantation.1 passage
• Locoregional and Overall Recurrence After Neaodjuvant Endocrine Therapy Versus Chemotherapy in Postmenopausal Women With Estrogen Receptor+ HER2- Breast Cancer.1 passage
• Long-Term Survival Rates and Prognostic Factors of Cervix Cancer Treated by Different Modalities.1 passage
• Long-Term Vitamin K Antagonists and Cancer Risk: A Systematic Review and Meta-Analysis.1 passage
• Long-term Oncologic Impact of Positive Anterior and Posterior Surgical Margins After Radical Prostatectomy.1 passage
• Long-term Outcome After Fractionated Radiotherapy for Pituitary Adenoma: The Curse of the Secretory Tumor.1 passage
• Long-term Outcome of Prostate Cancer Patients Who Exhibit Biochemical Failure Despite Salvage Radiation Therapy After Radical Prostatectomy.1 passage
• Long-term Outcomes After Definitive Radiation Therapy for Solitary Plasmacytoma.1 passage
• Long-term Outcomes After Gamma Knife Radiosurgery for Meningiomas.1 passage
• Long-term Outcomes After Radiosurgery for Temporal Bone Paragangliomas.1 passage
• Long-term Outcomes Following Radiation Therapy For Prostate Cancer Patients With Lymph Node Metastases at Diagnosis Treated With and Without Surgery.1 passage
• Long-term Outcomes Following Radiotherapy for Adolescent Patients With Nonmetastatic WHO Type III Nasopharyngeal Carcinoma.1 passage
• Long-term Outcomes With Ifosfamide-based Hypofractionated Preoperative Chemoradiotherapy for Extremity Soft Tissue Sarcomas.1 passage
• Long-term Outcomes and Complications in Pediatric Ewing Sarcoma.1 passage
• Long-term Treatment Outcomes for Locally Advanced Esophageal Cancer: A Single-Institution Experience.1 passage
• Long-term survival with paclitaxel and gemcitabine for germ cell tumors after progression following high-dose chemotherapy with tandem transplant.1 passage
• Longer Course of Induction Chemotherapy Followed by Chemoradiation Favors Better Survival Outcomes for Patients With Locally Advanced Pancreatic Cancer.1 passage
• Longitudinal DSC-MRI for Distinguishing Tumor Recurrence From Pseudoprogression in Patients With a High-grade Glioma.1 passage
• Low Frequency of Mutation Testing in the United States: An Analysis of 3866 GIST Patients.1 passage
• Low Toxicity in Inflammatory Bowel Disease Patients Treated With Abdominal and Pelvic Radiation Therapy.1 passage
• Low-Dose-Rate Brachytherapy Boosting Concurrent Chemoradiation as a Definitive Treatment Modality for Cervical Cancer: Long-term Clinical Results of Outcomes and Associated Toxicity.1 passage
• Lower Levels of Trust in the Medical Profession Among White, Younger, and More-educated Individuals With Cancer.1 passage
• Lung Metastasectomy in the Treatment of Rectal Cancer Gives Little if Any Benefit Compared With the Importance of Control at the Primary Cancer Site.1 passage
• Lymph Node Burden as a Predictive Factor for Selective Chemoradiotherapy in Patients With Locally Advanced Gastric Cancer After a D2 Dissection: A Retrospective Study.1 passage
• Lymph Node Ratio-based Staging System Outperforms the Seventh AJCC System for Gastric Cancer: Validation Analysis With National Taiwan University Hospital Cancer Registry.1 passage
• Lymphovascular Invasion in Endometrial Cancer: Prognostic Value and Implications on Adjuvant Radiation Therapy Use.1 passage
• MGMT Testing in Glioblastomas: Pitfalls and Opportunities.1 passage
• MUC1 as a potential target in anticancer therapies.1 passage
• MYC and human telomerase gene (TERC) copy number gain in early-stage non-small cell lung cancer.1 passage
• Maintenance Therapy in Metastatic Solid Tumors: Innovative Strategy or Simple Second-line Treatment?1 passage
• Malignant Peripheral Nerve Sheath Tumors: A Single Institution's Experience Using Combined Surgery and Radiation Therapy.1 passage
• Management Strategies for Patients With Epithelioid Hemangioendothelioma: Charting an Indolent Disease Course.1 passage
• Management of Metastatic Pure Teratoma in Chemotherapy Naive Patients With Testicular Primaries.1 passage
• Management of Postprostatectomy Biochemical Relapse With Salvage Radiotherapy: Results of an International Survey.1 passage
• Management of Skin Reactions During Cetuximab Treatment in Association With Chemotherapy or Radiotherapy: Update of the Italian Expert Recommendations.1 passage
• Management of Unplanned Excision for Soft-Tissue Sarcoma With Preoperative Radiotherapy Followed by Definitive Resection.1 passage
• Management of Unresectable T4b Esophageal Cancer: Practice Patterns and Outcomes From the National Cancer Data Base.1 passage
• Matched-pair Analysis for Survival Endpoints Between Women With Early-stage Uterine Carcinosarcoma and Uterine Serous Carcinoma.1 passage
• Medical Cannabis in Cancer Patients: A Survey of a Community Hematology Oncology Population.1 passage
• Medicare Cancer Screening in the Context of Clinical Guidelines: 2000 to 2012.1 passage
• Meningioma in Breast Cancer Patients: Population-based Analysis of Clinicopathologic Characteristics.1 passage
• Mental Health Disorders are More Common in Colorectal Cancer Survivors and Associated With Decreased Overall Survival.1 passage
• Metabolic Responses to Metformin in Inoperable Early-stage Non-Small Cell Lung Cancer Treated With Stereotactic Radiotherapy: Results of a Randomized Phase II Clinical Trial.1 passage
• Metastasis to the thyroid gland: report of a large series from the Mayo Clinic.1 passage
• Metastatic malignant transformation of teratoma to primitive neuroectodermal tumor (PNET): results with PNET-based chemotherapy.1 passage
• Metformin Does Not Predict for Prostate Cancer Diagnosis, Grade, or Volume of Disease After Transperineal Template-guided Mapping Biopsy.1 passage
• Metformin Use and Kidney Cancer Survival Outcomes: A Systematic Review and Meta-Analysis.1 passage
• Microsatellite Instability and Adjuvant Chemotherapy in Stage II Colon Cancer.1 passage
• Modern Management of High-risk Soft Tissue Sarcoma With Neoadjuvant Chemoradiation: A Single-center Experience.1 passage
• Modern Outcomes Following Treatment of Hepatocellular Carcinoma in Hereditary Hemochromatosis: A Matched Cohort Study.1 passage
• Modified-BEP Chemotherapy in Patients With Germ-Cell Tumors Treated at a Comprehensive Cancer Center.1 passage
• Mohs Micrographic Surgery Volume and Payment Patterns Among Dermatologists in the Medicare Population, 2013.1 passage
• Molecular Predictors of Response to Neoadjuvant Chemoradiation for Rectal Cancer.1 passage
• Mortality After Stereotactic Radiosurgery for Brain Metastases and Implications for Optimal Utilization: A National Cancer Database Study.1 passage
• Mucinous Adenocarcinoma of the Endometrium Compared With Endometrioid Endometrial Cancer: A SEER Analysis.1 passage
• Multiple Endocrine Disruption by the MET/ALK Inhibitor Crizotinib in Patients With Non-small Cell Lung Cancer.1 passage
• Multiple Site SBRT in Pediatric, Adolescent, and Young Adult Patients With Recurrent and/or Metastatic Sarcoma.1 passage
• Multispecialist Care and Mortality in Hepatocellular Carcinoma.1 passage
• Mutations in DNA Repair Genes and Clinical Outcomes of Patients With Metastatic Colorectal Cancer Receiving Oxaliplatin or Irinotecan-containing Regimens.1 passage
• Myoepithelioma of Soft Tissues: A Single Institution Retrospective Case Series.1 passage
• Nanoliposomal Irinotecan and Metronomic Temozolomide for Patients With Recurrent Glioblastoma: BrUOG329, A Phase I Brown University Oncology Research Group Trial.1 passage
• National Burden of Hospitalization Due to Cutaneous Melanoma in Adolescents and Young Adults.1 passage
• Nationwide Outcomes of Advanced Melanoma According to BRAFV600 Status.1 passage
• Nationwide Patterns of Pathologic Fractures Among Patients Hospitalized With Bone Metastases.1 passage
• Neoadjuvant Chemotherapy Treatment Modifications in Ovarian Carcinoma: The Impact on Surgical Outcome and Progression-free Survival.1 passage
• Neoadjuvant Interdigitated Chemoradiotherapy Using Mesna, Doxorubicin, and Ifosfamide for Large, High-grade, Soft Tissue Sarcomas of the Extremity: Improved Efficacy and Reduced Toxicity.1 passage
• Neoadjuvant Phase II Trial of Chemoradiotherapy in Patients With Resectable and Borderline Resectable Pancreatic Cancer.1 passage
• Neoadjuvant Therapy for Pancreatic Cancer: Systematic Review of Postoperative Morbidity, Mortality, and Complications.1 passage
• Neuro-oncology Multidisciplinary Clinic and Improvements in Patient Outcome.1 passage
• Neurocognitive Deficits After Radiation Therapy for Brain Malignancies.1 passage
• Nivolumab in the Treatment of Metastatic Renal Cell Carcinoma: A Cost-Utility Analysis.1 passage
• Novel Dose Escalation Approaches for Stereotactic Body Radiotherapy to Adrenal Oligometastases: A Single-Institution Experience.1 passage
• Novel Immunotherapeutic Agents for the Treatment of Multiple Myeloma.1 passage
• Nuclear Medicine Therapy With 223Radium-dichloride for Osseous Metastases in Prostate Carcinoma.1 passage
• Obesity is Independently Associated With Increased Risk of Hepatocellular Cancer-related Mortality: A Systematic Review and Meta-Analysis.1 passage
• Obstructive sleep apnea and fatigue in head and neck cancer patients.1 passage
• Off-Target Effects of BCR-ABL and JAK2 Inhibitors.1 passage
• Older Patients With Early-stage Breast Cancer: Adjuvant Radiation Therapy and Predictive Factors for Cancer-related Death.1 passage
• Oligorecurrent Nodal Prostate Cancer: Long-term Results of an Elective Nodal Irradiation Approach.1 passage
• Oncologic Accuracy of Image-guided Percutaneous Core-Needle Biopsy of Peripheral Nerve Sheath Tumors at a High-volume Sarcoma Center.1 passage
• Oncologic Outcome of ypT1-2N0 Rectal Cancer After Neoadjuvant Chemoradiotherapy Compared With pT1-2N0 Rectal Cancer.1 passage
• Oncologic and Functional Hazards of Obesity Among Patients With Locally Advanced Rectal Cancer Following Neoadjuvant Chemoradiation Therapy.1 passage
• Oncoplastic surgery and radiation therapy for breast conservation: early outcomes.1 passage
• Oral Platelet Gel Supernatant Plus Supportive Medical Treatment Versus Supportive Medical Treatment in the Management of Radiation-induced Oral Mucositis: A Matched Explorative Active Control Trial by Propensity Analysis.1 passage
• Outcome After Surgery for Extremity Soft Tissue Sarcoma in Patients Presenting With Metastasis at Diagnosis.1 passage
• Outcome of Locally Advanced Esophageal Cancer Patients Treated With Perioperative Chemotherapy and Chemoradiotherapy Followed by Surgery.1 passage
• Outcome of Transplant-fallout Patients With Unresectable Cholangiocarcinoma.1 passage
• Outcome of adjuvant therapy in biliary tract cancers.1 passage
• Outcomes After Curative Thoracic Radiotherapy in Patients With Coronary Artery Disease and Existing Cardiac Stents.1 passage
• Outcomes After Multidisciplinary Treatment of Inflammatory Breast Cancer in the Era of Neoadjuvant HER2-directed Therapy.1 passage
• Outcomes Following Hypofractionated Stereotactic Radiotherapy in the Management of Brain Metastases.1 passage
• Outcomes and Characteristics of Patients Receiving Second-line Therapy for Advanced Pancreatic Cancer.1 passage
• Outcomes and Utilization of Adjuvant Chemotherapy for Stage II Colon Cancer in the Oxaliplatin Period: A SEER-Medicare Analysis.1 passage
• Outcomes and the Role of Primary Histology Following LINAC-based Stereotactic Radiation for Sarcoma Brain Metastases.1 passage
• Outcomes for Anaplastic Glioma Treated With Radiation Therapy With or Without Concurrent Temozolomide.1 passage
• Outcomes in Patients With Metastatic Pancreatic Adenocarcinoma With the Introduction of New Chemotherapeutic Drugs: 10-Year Experience of a Single NCI-designated Comprehensive Cancer Center.1 passage
• Outcomes of Adults With Ewing Sarcoma Family of Tumors (ESFT) of the Kidney: A Single-Institution Experience.1 passage
• Outcomes of Definitive Radiation Therapy for Primary Vaginal Carcinoma.1 passage
• Outcomes of Immune Checkpoint Inhibitor-related Diarrhea or Colitis in Cancer Patients With Superimposed Gastrointestinal Infections.1 passage
• Outcomes of Node-positive Breast Cancer Patients Treated With Accelerated Partial Breast Irradiation Via Multicatheter Interstitial Brachytherapy: The Pooled Registry of Multicatheter Interstitial Sites (PROMIS) Experience.1 passage
• Outcomes of Ramucirumab Plus Paclitaxel Among Patients With Previously Treated Metastatic Gastric/Lower Esophageal Cancer: A Real-world Study.1 passage
• Outcomes of Stereotactic Radiosurgery and Immunotherapy in Renal Cell Carcinoma Patients With Brain Metastases.1 passage
• Outcomes of small cell lung cancer patients treated with cisplatin-etoposide versus carboplatin-etoposide.1 passage
• Overall Survival Results of the Feasibility Study of Adjuvant Chemotherapy With Docetaxel Plus Cisplatin Followed by Long-term Single-agent Administration of S-1 in Patients With Completely Resected Non-Small Cell Lung Cancer: Thoracic Oncology Research Group (TORG) 0809.1 passage
• Overall Survival of Men and Women With Breast Cancer According to Tumor Subtype: A Population-based Study.1 passage
• Overview of Current Treatment Options and Investigational Targeted Therapies for Locally Advanced Squamous Cell Carcinoma of the Head and Neck.1 passage
• PPX and Concurrent Radiation for Newly Diagnosed Glioblastoma Without MGMT Methylation: A Randomized Phase II Study: BrUOG 244.1 passage
• Pain Intensity and Pain Interference in Patients With Lung Cancer: A Pilot Study of Biopsychosocial Predictors.1 passage
• Palliative Irradiation of Sacral Metastases: Must the Entire Bone Be Treated?1 passage
• Pancreatectomy Versus Conservative Management for Pancreatic Cancer: A Question of Lead-time Bias.1 passage
• Pancreatic Cancer Clinical Treatment Trials Accrual: A Closer Look at Participation Rates.1 passage
• Paragangliomas of the Head and Neck: Local Control and Functional Outcome Following Fractionated Stereotactic Radiotherapy.1 passage
• Parameters Associated With Mandibular Osteoradionecrosis.1 passage
• Paraneoplastic leukemoid reaction in solid tumors.1 passage
• Partner's Perspective on Long-term Sexual Dysfunction After Prostate Cancer Treatment.1 passage
• Pathologic Response to Neoadjuvant Therapy is Associated With Improved Long-term Survival in High-risk Primary Localized Malignant Peripheral Nerve Sheath Tumors.1 passage
• Pathologic Response to Primary Systemic Therapy With FOLFIRINOX in Patients With Resectable Pancreatic Cancer.1 passage
• Patient Adherence in an Academic Medical Center's Low-dose Computed Tomography Screening Program.1 passage
• Patient Selection for Adjuvant Chemotherapy in High-Risk Stage II Colon Cancer: A Systematic Review and Meta-Analysis.1 passage
• Patient-reported Adherence to Adjuvant Aromatase Inhibitor Therapy Using the Morisky Medication Adherence Scale: An Evaluation of Predictors.1 passage
• Patient-reported Long-term Cosmetic Outcomes Following Short Fractionation Whole Breast Radiotherapy With Boost.1 passage
• Patient-reported Quality of Life After SBRT, LDR, and HDR Brachytherapy for Prostate Cancer: A Comparison of Outcomes.1 passage
• Patient-reported Urinary, Bowel, and Sexual Function After Hypofractionated Intensity-modulated Radiation Therapy for Prostate Cancer: Results From a Randomized Trial.1 passage
• Pattern of Marginal Local Failure in a Phase II Trial of Neoadjuvant Chemotherapy and Stereotactic Body Radiation Therapy for Resectable and Borderline Resectable Pancreas Cancer.1 passage
• Patterns of Adjuvant Therapy Utilization in Uterine Carcinosarcoma Stages I to III: A National Cancer Database Analysis.1 passage
• Patterns of Care and Outcomes of Definitive External Beam Radiotherapy and Radioembolization for Localized Hepatocellular Carcinoma: A Propensity Score-adjusted Analysis.1 passage
• Patterns of Care and Outcomes of Elderly Esophageal Cancer Patients Not Meeting Age-based Criteria of the CROSS Trial.1 passage
• Patterns of Care and Outcomes of Hypofractionated Chemoradiation Versus Conventionally Fractionated Chemoradiation for Glioblastoma in the Elderly Population.1 passage
• Patterns of Care and Survival in Elderly Patients With Locally Advanced Soft Tissue Sarcoma.1 passage
• Patterns of Care for Stage II-III Rectosigmoid Cancers in the United States, 2004-2015.1 passage
• Patterns of Failure in Patients With Adult Medulloblastoma Presenting Without Extraneural Metastasis.1 passage
• Patterns of Long-term Cancer Survivorship Care in a National Cancer Institute-Designated Comprehensive Cancer Center.1 passage
• Patterns of Postdiagnosis Depression Among Late-Stage Cancer Patients: Do Racial/Ethnic and Sex Disparities Exist?1 passage
• Pelvic Reirradiation Utilizing Pulsed Low-dose Rate Radiation Therapy.1 passage
• Pembrolizumab for the Treatment of Advanced Salivary Gland Carcinoma: Findings of the Phase 1b KEYNOTE-028 Study.1 passage
• Perineural Invasion Predicts for Distant Metastasis in Locally Advanced Rectal Cancer Treated With Neoadjuvant Chemoradiation and Surgery.1 passage
• Perioperative Mortality in Nonelderly Adult Patients With Cancer: A Population-based Study Evaluating Health Care Disparities in the United States According to Insurance Status.1 passage
• Persistent Use of Extended Fractionation Palliative Radiotherapy for Medicare Beneficiaries With Metastatic Breast Cancer, 2011 to 2014.1 passage
• Phase I Dose-Escalation Study of Weekly Paclitaxel and Cisplatin Followed by Radical Hysterectomy in Stages IB2 and IIA2 Cervical Cancer.1 passage
• Phase I Study of Amrubicin and Cyclophosphamide in Patients With Advanced Solid Organ Malignancies: HOG LUN 07-130.1 passage
• Phase I Study of Aurora A Kinase Inhibitor Alisertib (MLN8237) in Combination With Selective VEGFR Inhibitor Pazopanib for Therapy of Advanced Solid Tumors.1 passage
• Phase I Study of Docetaxel Plus Nedaplatin in Patients With Metastatic or Recurrent Esophageal Squamous Cell Carcinoma After Cisplatin Plus 5-Fluorouracil Treatment.1 passage
• Phase I Study of Docetaxel and Temsirolimus in Refractory Solid Tumors.1 passage
• Phase I Study of IGF-Methotrexate Conjugate in the Treatment of Advanced Tumors Expressing IGF-1R.1 passage
• Phase I Study of Muscadine Grape Extract for Patients With Advanced Cancer.1 passage
• Phase I Study of Pazopanib and Ixabepilone in Patients With Solid Tumors.1 passage
• Phase I Study of Sorafenib and Vorinostat in Advanced Hepatocellular Carcinoma.1 passage
• Phase I Trial Using Induction Ciplatin, Docetaxel, 5-FU and Erlotinib Followed by Cisplatin, Bevacizumab and Erlotinib With Concurrent Radiotherapy for Advanced Head and Neck Cancer.1 passage
• Phase I Trial of Dose-escalated Whole Liver Irradiation With Hepatic Arterial Fluorodeoxyuridine/Leucovorin and Streptozotocin Followed by Fluorodeoxyuridine/Leucovorin and Chemoembolization for Patients With Neuroendocrine Hepatic Metastases.1 passage
• Phase I and pharmacokinetic study of erlotinib administered in combination with amrubicin in patients with previously treated, advanced non-small cell lung cancer.1 passage
• Phase I/II Dose-Escalation Trial of 3-Fraction Stereotactic Radiosurgery for Resection Cavities From Large Brain Metastases: Health-related Quality of Life Outcomes.1 passage
• Phase I/II Study of Hepatic Arterial Infusion of Nab-paclitaxel in Patients With Metastatic Melanoma to the Liver.1 passage
• Phase I/II Study of S-1 Plus Cisplatin Alternating With S-1 Plus Docetaxel in Patients With Advanced Gastric Cancer.1 passage
• Phase I/II Trial of Neoadjuvant Oregovomab-based Chemoimmunotherapy Followed by Stereotactic Body Radiotherapy and Nelfinavir For Locally Advanced Pancreatic Adenocarcinoma.1 passage
• Phase IB Study of Induction Chemotherapy With XELOX, Followed by Radiation Therapy, Carboplatin, and Everolimus in Patients With Locally Advanced Esophageal Cancer.1 passage
• Phase II Study of Adjuvant Chemoradiotherapy Using Docetaxel/Cisplatin/5-Fluorouracil Before and After Intensity-modulated Radiotherapy With Concurrent Docetaxel in Patients With Completely (R0) Resected Gastric Carcinoma.1 passage
• Phase II Study of Modified FOLFOX6 With Bevacizumab in Metastatic Gastroesophageal Adenocarcinoma.1 passage
• Phase II Study of Neoadjuvant Chemotherapy With S-1 and CDDP in Patients With Lymph Node Metastatic Stage II or III Gastric Cancer.1 passage
• Phase II Study of Preoperative Capecitabine and Oxaliplatin-based Intensified Chemoradiotherapy With or Without Induction Chemotherapy in Patients With Locally Advanced Rectal Cancer and Synchronous Liver-limited Resectable Metastases.1 passage
• Phase II Study of the Modified Weekly Nab-paclitaxel Regimen in Previously Treated Patients With Advanced Non-Small Cell Lung Cancer.1 passage
• Phase II Trial of Eribulin in Patients With Metastatic Hormone Refractory Prostate Cancer: A Trial of the ECOG-ACRIN Cancer Research Group (E5805).1 passage
• Phase II Trial of Target-guided Personalized Chemotherapy in First-line Metastatic Colorectal Cancer.1 passage
• Phase II study of nab-paclitaxel and bevacizumab as first-line therapy for patients with unresectable stage III and IV melanoma.1 passage
• Phosphorylated Akt Expression as a Favorable Prognostic Factor for Patients Undergoing Curative Resection and Adjuvant Chemoradiotherapy for Proximal Extrahepatic Bile Duct Cancer.1 passage
• Population-based Analysis of Treatment and Survival in Women Presenting With Brain Metastasis at Initial Breast Cancer Diagnosis.1 passage
• Population-based Assessment of Intermittent Androgen Deprivation Therapy Utilization for Relapsed, Nonmetastatic, Hormone-sensitive Adenocarcinoma of the Prostate.1 passage
• Population-based Treatment Patterns and Outcomes for Stage III Non-Small Cell Lung Cancer Patients: A Real-world Evidence Study.1 passage
• Positive Surgical Margins in Favorable-Stage Differentiated Thyroid Cancer.1 passage
• Postoperative Observation Versus Radiotherapy for Pathologic N1 Oral Cavity Squamous Cell Carcinoma.1 passage
• Postoperative treatment with docetaxel, cisplatin, and capecitabine (DCX) and chemoradiotherapy (CRT) with capecitabine for resected gastric adenocarcinoma.1 passage
• Potential Role of Single Nucleotide Polymorphisms of XRCC1, XRCC3, and RAD51 in Predicting Acute Toxicity in Rectal Cancer Patients Treated With Preoperative Radiochemotherapy.1 passage
• Practical Heart Sparing Breast Cancer Radiation Therapy Using Continuous Positive Airway Pressure (CPAP) in Resource-Limited Radiation Oncology Clinics.1 passage
• Pre-ESRD Care and Mortality in Incident ESRD Patients With Multiple Myeloma.1 passage
• Prechemotherapy Hemoglobin Levels as a Predictive Factor of Ovarian Cancer Survival: A Systematic Review and Meta-Analysis.1 passage
• Predictive Impact of Clinical Benefit in Chemotherapy-treated Advanced Pancreatic Cancer Patients in Northern Alberta.1 passage
• Predictive Roles of HER2 Gene Amplification and Neutrophil-to-Lymphocyte Ratio on Survival in HER2-Positive Advanced Gastric Cancer Treated With Trastuzumab-Based Chemotherapy.1 passage
• Predictors and Patterns of Local, Regional, and Distant Failure in Squamous Cell Carcinoma of the Vulva.1 passage
• Predictors of Distant Recurrence Following Stereotactic Body Radiation Therapy for Stage I Non-Small Cell Lung Cancer.1 passage
• Predictors of Hematologic Toxicity and Chemotherapy Dose Intensity in Patients Undergoing Chemoradiation for Pancreatic Cancer.1 passage
• Predictors of Local Recurrence in Patients With Myxofibrosarcoma.1 passage
• Predictors of locoregional outcome in HER2-overexpressing breast cancer treated with neoadjuvant chemotherapy.1 passage
• Preoperative Radiation Performed at a Nonsarcoma Center May Lead to Increased Wound Complications Following Resection in Patients With Soft Tissue Sarcomas.1 passage
• Preoperative Radiosurgery for Soft Tissue Sarcoma.1 passage
• Preradiation Chemotherapy for Adult High-risk Medulloblastoma: A Trial of the ECOG-ACRIN Cancer Research Group (E4397).1 passage
• Preradiotherapy Tumor Volume in Local Control of Squamous Cell Carcinoma of the Supraglottic Larynx.1 passage
• Pretreatment Tumor Thickness as a Predictor of Pathologic Complete Response to Neoadjuvant Chemoradiation Therapy for Stage II/III Rectal Adenocarcinoma.1 passage
• Prevalence, Predictors, and Implications for Appropriate Use of Active Surveillance Management Among Black Men Diagnosed With Low-risk Prostate Cancer.1 passage
• Prevention of Trastuzumab and Anthracycline-induced Cardiotoxicity Using Angiotensin-converting Enzyme Inhibitors or β-blockers in Older Adults With Breast Cancer.1 passage
• Primary Cardiac Sarcoma: 25-Year Cleveland Clinic Experience.1 passage
• Primary Debulking Surgery Versus Neoadjuvant Chemotherapy in Advanced Epithelial Ovarian Cancer: A Propensity-matched Analysis.1 passage
• Primary Pulmonary Carcinoid Tumor: A Long-term Single Institution Experience.1 passage
• Primary Retroperitoneal Mucinous Cystic Neoplasm: Authors' Experience and Review of the Literature.1 passage
• Primary Tumor Thickness is a Prognostic Factor in Stage IV Melanoma: A Retrospective Study of Primary Tumor Characteristics.1 passage
• Primary and Radiation-induced Breast Angiosarcoma: Clinicopathologic Predictors of Outcomes and the Impact of Adjuvant Radiation Therapy.1 passage
• Prior Treatment for Non-small Cell Lung Cancer Is Associated With Improved Survival in Patients who Undergo Definitive Stereotactic Body Radiation Therapy for a Subsequent Lung Malignancy: A Retrospective Multivariate and Matched Pair Analysis.1 passage
• Prognosis and Management of Thick and Ultrathick Melanoma.1 passage
• Prognostic Factors as a Function of Disease-free Interval After Definitive (Chemo)radiation for Non-Small Cell Lung Cancer Using Conditional Survival Analysis.1 passage
• Prognostic Factors of Second-line Immune Checkpoint Inhibitors in Patients With Advanced-stage Non-Small Cell Lung Cancer: A Multicenter, Retrospective Study.1 passage
• Prognostic Factors, Treatment, and Outcomes in Early Stage, Invasive Papillary Breast Cancer: A SEER Investigation of Less Aggressive Treatment in a Favorable Histology.1 passage
• Prognostic Impact of Missed Chemotherapy Doses During Chemoradiation Therapy for Non-Small Cell Lung Cancer.1 passage
• Prognostic Nomogram for Hepatitis B Virus-related Hepatocellular Carcinoma With Adjuvant Transarterial Chemoembolization After Radical Resection.1 passage
• Prognostic Scoring Models for Patients Undergoing Sorafenib Treatment for Advanced Stage Hepatocellular Carcinoma in Real-Life Practice.1 passage
• Prognostic Significance of Disease Control at 12 Weeks in Patients With Advanced Pancreatic Cancer Receiving FOLFIRINOX as First-line Chemotherapy.1 passage
• Prognostic Significance of Nodal Location and Ratio in Stage IIIC Endometrial Carcinoma Among a Multi-Institutional Academic Collaboration.1 passage
• Prognostic Significance of Nodal Ratio in Patients Undergoing Adjuvant Chemoradiotherapy After Curative Resection for Ampullary Cancer.1 passage
• Prognostic Significance of Nuclear Factor Kappa B Expression in Locally Advanced Cervical Cancer Patients Treated Definitively With Concurrent Chemoradiation.1 passage
• Prognostic Significance of Preoperative Prognostic Nutritional Index in Patients Undergoing Nephrectomy for Nonmetastatic Renal Cell Carcinoma.1 passage
• Prognostic Significance of Standardized Uptake Value of Lymph Nodes on Survival for Stage III Non-small Cell Lung Cancer Treated With Definitive Concurrent Chemoradiotherapy.1 passage
• Prognostic Significance of Tumor Subtypes in Women With Breast Cancer According to Stage: A Population-based Study.1 passage
• Prognostic Value of Ki-67 Labeling Index and Postoperative Radiotherapy in WHO Grade II Meningioma.1 passage
• Prognostic Value of Preoperative Imaging: Comparing 18F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography to Computed Tomography Alone for Preoperative Planning in High-risk Histology Endometrial Carcinoma.1 passage
• Prognostic Value of Serum NPY Hypermethylation in Neoadjuvant Chemoradiotherapy for Rectal Cancer: Secondary Analysis of a Randomized Trial.1 passage
• Prognostic Value of the Tumor Immune Microenvironment for Early-stage, Non-Small Cell Lung Cancer.1 passage
• Prognostic significance of Ki67 expression in malignant peritoneal mesothelioma.1 passage
• Programmed Cell Death-Ligand 1 (PD-L1) Expression in Anal Cancer.1 passage
• Prospective Evaluation of Multinational Association of Supportive Care in Cancer Risk Index Score for Gynecologic Oncology Patients With Febrile Neutropenia.1 passage
• Prospective Longitudinal Assessment of Health-related Quality of Life in Patients With Brain Metastases Undergoing Radiation Therapy.1 passage
• Prospective Translational Study Investigating Molecular PrEdictors of Resistance to First-Line PazopanIb in Metastatic reNal CEll Carcinoma (PIPELINE Study).1 passage
• Psychiatric Disturbance or Parkinsonism as a Presentation of CNS Lymphoma: Observational Retrospective Study and Review of Literature.1 passage
• Quality of Life Perception, Cognitive Function, and Psychological Status in a Real-world Population of Glioblastoma Patients Treated With Radiotherapy and Temozolomide: A Single-center Prospective Study.1 passage
• Quantifying Decreased Radiation Exposure From Modern CT Scan Technology and Surveillance Programs of Germ Cell Tumors.1 passage
• Ra-223 Treatment for Bone Metastases in Castrate-Resistant Prostate Cancer: Practical Management Issues for Patient Selection.1 passage
• Racial Disparities in Extremity Soft-Tissue Sarcoma Outcomes: A Nationwide Analysis.1 passage
• Racial Disparities in Time to Treatment Initiation and Outcomes for Early Stage Anal Squamous Cell Carcinoma.1 passage
• Racial and Geographic Disparities in Endocrine Therapy Adherence Among Younger Breast Cancer Survivors.1 passage
• Radiation Therapy for Aneurysmal Bone Cysts.1 passage
• Radiation Therapy for Very Elderly Patients Aged 80 Years and Older With Squamous Cell Carcinoma of the Uterine Cervix.1 passage
• Radiation Therapy for the Management of Brain Metastases.1 passage
• Radiation Therapy in the Management of Soft Tissue Sarcoma: A Clinician's Guide to Timing, Techniques, and Targets.1 passage
• Radiation Treatment for Ewing Sarcoma Family of Tumors in Adult Patients: A Single Institution's Experience Over 40 Years.1 passage
• Radiation and Immunotherapy in High-grade Gliomas: Where Do We Stand?1 passage
• Radiation therapy for mucosal melanoma of the head and neck.1 passage
• Radioembolization With Yttrium-90 Resin Microspheres in Hepatocellular Carcinoma: A Multicenter Prospective Study.1 passage
• Radiographic Response of Vessel Involvement and Resectability After Neoadjuvant Chemoradiation in Patients With Locally Advanced Pancreatic Cancer.1 passage
• Radiotherapy Alone or With Chemotherapy in the Management of Carcinoma of the Supraglottic Larynx: A 25-Year Community Hospital Experience.1 passage
• Radiotherapy and Male Breast Cancer: A Population-based Registry Analysis.1 passage
• Radiotherapy for Adult Soft Tissue Sarcomas of the Head and Neck.1 passage
• Radiotherapy for Brain Metastases From Renal Cell Carcinoma in the Targeted Therapy Era: The University of Rochester Experience.1 passage
• Radiotherapy in Early-stage Gastric MALT: Improved Survival Without Increased Cardiac Death.1 passage
• Radiotherapy in the Management of Orbital Lymphoma: A Single Institution's Experience Over 4 Decades.1 passage
• Randomized Controlled Study to Compare Uncovered Stent Versus Covered Stent as Percutaneous Endoprosthesis for Malignant Biliary Obstruction (JIVROSG-0207).1 passage
• Randomized Phase II Study of the X-linked Inhibitor of Apoptosis (XIAP) Antisense AEG35156 in Combination With Sorafenib in Patients With Advanced Hepatocellular Carcinoma (HCC).1 passage
• Randomized Phase II Trial of Irinotecan/Docetaxel or Irinotecan/Docetaxel Plus Cetuximab for Metastatic Pancreatic Cancer: An Eastern Cooperative Oncology Group Study.1 passage
• Randomized, Prospective, Open-label Phase III Trial Comparing Mebo Ointment With Biafine Cream for the Management of Acute Dermatitis During Radiotherapy for Breast Cancer.1 passage
• Rapid Early Tumor Progression is Prognostic in Glioblastoma Patients.1 passage
• Rapid Initiation of Neoadjuvant Chemoradiotherapy After Diagnosis is Associated With Improved Pathologic Response in Locally Advanced Rectal Cancer.1 passage
• Real-World Adherence to Guideline-Recommended Treatment for Small Cell Lung Cancer.1 passage
• Real-world Outcomes Among Patients Treated With Gemcitabine-based Therapy Post-FOLFIRINOX Failure in Advanced Pancreatic Cancer.1 passage
• Real-world Patterns of Adjuvant Chemotherapy Following Neoadjuvant Chemoradiation for Patients With Resected Rectal Adenocarcinoma.1 passage
• Recent Health Care Expenditure Trends Among Adult Cancer Survivors in United States, 2009-2016.1 passage
• Recent Trends and Overall Survival of Young Versus Older Adults With Stage II to III Rectal Cancer Treated With and Without Surgery in the United States, 2010-2015.1 passage
• Rectal Culture and Sensitivity Analysis for Reducing Sepsis Risk After Fiducial Marker Placement.1 passage
• Reduced-intensity FOLFOXIRI in Treating Refractory Metastatic Colorectal Cancer: A Pilot Study.1 passage
• Refusal of Radiation Results in Inferior Survival in Endometrial Cancer.1 passage
• Regional Lymph Node Metastases in Groin Sarcomas: A Diagnostic and Therapeutic Challenge.1 passage
• Reirradiation in Conservative Salvage of Recurrent Soft-tissue Sarcoma: An Analysis of Treatment Efficacy and Toxicities.1 passage
• Resection of Colorectal Cancer With Versus Without Preservation of Inferior Mesenteric Artery.1 passage
• Results of Dose-adapted Salvage Radiotherapy After Radical Prostatectomy Based on an Endorectal MRI Target Definition Model.1 passage
• Results of a phase II study of Short-course Accelerated Radiation Therapy (SHARON) for multiple brain metastases.1 passage
• Results of the NRG Oncology/RTOG 0848 Adjuvant Chemotherapy Question-Erlotinib+Gemcitabine for Resected Cancer of the Pancreatic Head: A Phase II Randomized Clinical Trial.1 passage
• Retroperitoneal liposarcoma: a comprehensive review.1 passage
• Retrospective Analysis of Cisplatin Nephrotoxicity in Patients With Head and Neck Cancer Receiving Outpatient Treatment With Concurrent High-dose Cisplatin and Radiotherapy.1 passage
• Risk Analysis of Pneumonitis in Taxane Therapy After Chemoradiotherapy for Patients With Metastatic or Recurrent Esophageal Cancer.1 passage
• Risk Factors for Emergency Room and Hospital Care Among Patients With Solid Tumors on Immune Checkpoint Inhibitor Therapy.1 passage
• Risk of Immune-related Adverse Events in Melanoma Patients With Preexisting Autoimmune Disease Treated With Immune Checkpoint Inhibitors: A Population-based Study Using SEER-Medicare Data.1 passage
• Risk of Recurrence and 10-Year Outcomes in Surgically Treated Nonmelanoma Skin Cancer in Cardiac and Liver Transplant Recipients.1 passage
• Role of Perioperative Chemotherapy in Lymph Node-negative Esophageal Cancer After Resection: A Population-based Study With Propensity Score-matched Analysis.1 passage
• Role of Stereotactic Body Radiation Therapy in Early Stage Small Cell Lung Cancer in the Era of Lung Cancer Screening: A Systematic Review.1 passage
• Role of radiation therapy as immune activator in the era of modern immunotherapy for metastatic malignant melanoma.1 passage
• Routine Adaptive Replanning of p16-Positive Stage N2b Oropharyngeal Cancer: Quality Improvement or Waste of Time?1 passage
• Safety and Efficacy of Cabozantinib for Metastatic Nonclear Renal Cell Carcinoma: Real-world Data From an Italian Managed Access Program.1 passage
• Safety and Outcome Measures of First-in-Human Intraperitoneal α Radioimmunotherapy With 212Pb-TCMC-Trastuzumab.1 passage
• Safety of Abiraterone Acetate in Castration-resistant Prostate Cancer Patients With Concomitant Cardiovascular Risk Factors.1 passage
• Salvage radiation therapy improves metastasis-free survival for clinically aggressive and indolent prostate cancer recurrences after radical prostatectomy.1 passage
• Sample Size Calculation in Oncology Trials: Quality of Reporting and Implications for Clinical Cancer Research.1 passage
• Second-line Chemotherapy Prolongs Survival in Real World Patients With Advanced Biliary Tract and Gallbladder Cancers: A Multicenter Retrospective Population-based Cohort Study.1 passage
• Secondary Surgery Versus Chemotherapy for Recurrent Ovarian Cancer.1 passage
• Selection of Mediastinal Lymphoma Patients for Proton Therapy Within the Proton Collaborative Group Registry: Concordance With the ILROG Guidelines.1 passage
• Selective Internal Yttrium-90 Radioembolization Therapy (90Y-SIRT) Versus Best Supportive Care in Patients With Unresectable Metastatic Melanoma to the Liver Refractory to Systemic Therapy: Safety and Efficacy Cohort Study.1 passage
• Self-reported Conflicts of Interest and Trial Sponsorship of Clinical Trials in Prostate Cancer Involving Radiotherapy.1 passage
• Sepsis Hospitalizations With Versus Without Cancer: Epidemiology, Outcomes, and Trends in Nationwide Analysis From 2008 to 2017.1 passage
• Sequencing Ipilimumab Immunotherapy Before or After Chemotherapy (Nab-Paclitaxel and Bevacizumab) for the Treatment of BRAFwt (BRAF Wild-Type) Metastatic Malignant Melanoma: Results of a Study of Academic and Community Cancer Research United (ACCRU) RU261206I.1 passage
• Sequencing of Adjuvant Chemoradiation for Advanced Stage Endometrial Cancer: Outcomes and Toxicity Profiles.1 passage
• Sequencing of Chemotherapy and Radiotherapy for Newly Diagnosed Anaplastic Oligodendroglioma and Oligoastrocytoma.1 passage
• Seven-Year Outcomes Following Accelerated Partial Breast Irradiation Stratified by ASTRO Consensus Groupings.1 passage
• Sexual Dysfunction in Breast Cancer Survivors: Is it Surgical Modality or Adjuvant Therapy?1 passage
• Single-agent Bevacizumab in Recurrent Glioblastoma After Second-line Chemotherapy With Fotemustine: The Experience of the Italian Association of Neuro-Oncology.1 passage
• Single-institution Experience of SBRT for Lung Metastases in Sarcoma Patients.1 passage
• Six-Week Interval Between Preoperative Radiation and Surgery Is Associated With Fewer Major Wound Complications in Soft Tissue Sarcoma.1 passage
• Six-Year Results From a Phase I/II Trial for Hypofractionated Accelerated Partial Breast Irradiation Using a 2-Day Dose Schedule.1 passage
• Small Cell Carcinoma of the Esophagus: A Nationwide Analysis of Treatment and Outcome at Patient Level in Locoregional Disease.1 passage
• Smoking Decreases Survival in Locally Advanced Cervical Cancer Treated With Radiation.1 passage
• Social Network, Surgeon, and Media Influence on the Decision to Undergo Contralateral Prophylactic Mastectomy.1 passage
• Socioeconomic Determinants of the Use of Molecular Testing in Stage IV Colorectal Cancer.1 passage
• Soft Tissue Solitary Fibrous Tumor: Combined Surgery and Radiation Therapy Results in Excellent Local Control.1 passage
• Sparing bilateral neck level IB in oropharyngeal carcinoma and xerostomia outcomes.1 passage
• Speed of Accrual Into Phase III Oncology Trials: A Comparison Across Geographic Locations.1 passage
• Squamous non-small cell lung cancer as a distinct clinical entity.1 passage
• Stage I Lung SBRT Clinical Practice Patterns.1 passage
• Stage I and II Endometrial Adenocarcinoma: Analysis of 2009 FIGO Staging Revision and Impact on Survival by Adjuvant Therapy.1 passage
• Stage IIIC Endometrial Cancer: Relapse and Survival Outcomes in Women Treated With Pelvic or Extended Field Para-Aortic Nodal Radiation Therapy.1 passage
• Stage-specific Conditional Survival Among Young (Age Below 50 y) Versus Older (Age 50 y and Above) Adults With Colorectal Cancer in the United States.1 passage
• Statins as Potential Therapeutics for Lung Cancer: Molecular Mechanisms and Clinical Outcomes.1 passage
• Stereotactic Ablative Radiotherapy (SABR) for Large Renal Tumors: A Retrospective Case Series Evaluating Clinical Outcomes, Toxicity, and Technical Considerations.1 passage
• Stereotactic Body Radiation Therapy (SBRT) Combined With Chemotherapy for Unresected Pancreatic Adenocarcinoma.1 passage
• Stereotactic Body Radiation Therapy (SBRT) for Hepatocellular Carcinoma: High Rates of Local Control With Low Toxicity.1 passage
• Stereotactic Body Radiation Therapy as Salvage for Intrathoracic Recurrence in Patients With Previously Irradiated Locally Advanced Non-Small Cell Lung Cancer.1 passage
• Stereotactic Body Radiation Therapy for Intermediate-risk Prostate Cancer With VMAT and Real-time Electromagnetic Tracking: A Phase II Study.1 passage
• Stereotactic Body Radiotherapy for Elderly Patients With Medically Inoperable Pancreatic Cancer.1 passage
• Stereotactic Body Radiotherapy for Lung Metastases from Colorectal Cancer: Prognostic Factors for Disease Control and Survival.1 passage
• Stereotactic Body Radiotherapy for Oligometastatic Prostate Cancer Recurrence: A Meta-analysis.1 passage
• Stereotactic Body Radiotherapy for Palliation of Hematuria Arising From Urothelial Carcinoma of the Kidney in Unfavorable Surgical Candidates.1 passage
• Stereotactic Body Radiotherapy for Prostate Cancer: Where, When, and Who? A Bibliometric Analysis.1 passage
• Study of L-Asparaginase, Vincristine, and Dexamethasone Combined With Intensity-modulated Radiation Therapy in Early-Stage Nasal NK/T-Cell Lymphoma.1 passage
• Suboptimal Compliance With National Comprehensive Cancer Network Melanoma Guidelines: Who Is at Risk?1 passage
• Successful Ifosfamide Rechallenge in Soft-Tissue Sarcoma.1 passage
• Surgery and Adjuvant Radiation for High-risk Skin Adnexal Carcinoma of the Head and Neck.1 passage
• Surgery for Li Fraumeni syndrome: pushing the limits of surgical oncology.1 passage
• Surgical Intervention in Gastric Carcinoid is Associated With Improved Survival in Local and Regional Disease.1 passage
• Surgical Treatment of Gastrointestinal Stromal Tumors Located in the Stomach in the Imatinib Era.1 passage
• Surgical treatment of advanced gallbladder cancer.1 passage
• Surgical, Urinary, and Survival Outcomes of Nerve-sparing Versus Traditional Radical Hysterectomy: A Retrospective Cohort Study in China.1 passage
• Surveillance Mammography After Breast Conservation Therapy: Is Tomosynthesis Worth It?1 passage
• Surveillance Only for High-risk FIGO Stage IA/IB Malignant Ovarian Germ Cell Tumors: Results From a National Cancer Database.1 passage
• Survival Analysis of Cancer Patients With FIGO Stage IIIA Endometrial Cancer.1 passage
• Survival Benefit of Adjuvant Radiation Therapy in Node-positive Vulvar Cancer.1 passage
• Survival Benefit of Combination Chemotherapy in Elderly Patients With Metastatic Pancreatic Ductal Adenocarcinoma.1 passage
• Survival Implications of De Novo Versus Recurrent Metastatic Non-Small Cell Lung Cancer.1 passage
• Survival Outcome and Prognostic Factors After Pulmonary Metastasectomy in Sarcoma Patients: A 18-Year Experience at a Single High-volume Referral Center.1 passage
• Survival Outcomes After Adding Stereotactic Body Radiotherapy to Metastatic Renal Cell Carcinoma Patients Treated With Tyrosine Kinase Inhibitors.1 passage
• Survival Outcomes Improved in Contemporary Cohort of Patients With Pelvic or Abdominal Recurrence After Treatment for Stage I/II Endometrial Carcinoma.1 passage
• Survival Outcomes of Primary Intraocular Lymphoma: A Single-institution Experience.1 passage
• Survival Trends of Patients With Surgically Resected Gastric Cardia Cancer From 1988 to 2015: A Population-based Study in the United States.1 passage
• Survival of Patients With Multiple Intracranial Metastases Treated With Stereotactic Radiosurgery: Does the Number of Tumors Matter?1 passage
• Survivors' Perceptions of Quality of Colorectal Cancer Care by Sexual Orientation.1 passage
• Synovial Sarcoma of the Hand and Foot: An Institutional Review.1 passage
• Systematic Literature Review and Meta-Analysis of Response to First-Line Therapies for Advanced/Metastatic Urothelial Cancer Patients Who Are Cisplatin Ineligible.1 passage
• Systematic Review and Meta-Analysis on the Use of Photon-based Stereotactic Radiosurgery Versus Fractionated Stereotactic Radiotherapy for the Treatment of Uveal Melanoma.1 passage
• Systematic Review of Treatments for Colorectal Metastases in Elderly Patients to Guide Surveillance Cessation Following Hepatic Resection for Colorectal Liver Metastases.1 passage
• Systemic Immunostimulatory Effects of Radiation Therapy Improves the Outcomes of Patients With Advanced NSCLC Receiving Immunotherapy.1 passage
• Systemic Management for Nonmetastatic Castration-resistant Prostate Cancer: A Systematic Review and Network Meta-Analysis.1 passage
• Systemic Therapy in Advanced Cutaneous Squamous Cell Carcinoma (CSCC): The Roswell Park Experience and a Review of the Literature.1 passage
• Targeted Prostate Biopsy Gleason Score Heterogeneity and Implications for Risk Stratification.1 passage
• Targeting Tumor Metabolism With Statins During Treatment for Advanced-stage Pancreatic Cancer.1 passage
• Targeting the Mevalonate Pathway for Treating Lung Cancer.1 passage
• Testosterone for Managing Treatment-related Fatigue in Patients With Metastatic Renal Cell Carcinoma: A Phase 2 Randomized Study FARETES.1 passage
• The Association Between Chemoradiation-related Lymphopenia and Clinical Outcomes in Patients With Locally Advanced Pancreatic Adenocarcinoma.1 passage
• The Association Between Out-of-Pocket Costs and Adherence to Adjuvant Endocrine Therapy Among Newly Diagnosed Breast Cancer Patients.1 passage
• The Benefit of Adjuvant Radiotherapy in High-grade Nonmetastatic Retroperitoneal Soft Tissue Sarcoma: A SEER Analysis.1 passage
• The Benefit of Chemotherapy in Esophageal Cancer Patients With Residual Disease After Trimodality Therapy.1 passage
• The Birth of the Illegitimate Linear No-Threshold Model: An Invalid Paradigm for Estimating Risk Following Low-dose Radiation Exposure.1 passage
• The Cleveland Clinic experience with primary central nervous system lymphoma.1 passage
• The Effect of Adjuvant Pelvic Radiotherapy on Distant Metastasis for Uterine Carcinosarcoma.1 passage
• The Effect of Metformin on Prognosis in Patients With Locally Advanced Gastric Cancer Associated With Type 2 Diabetes Mellitus.1 passage
• The Effect of Receiving Treatment Within a Clinical Trial Setting on Survival and Quality of Care Perception in Advanced Stage Non-Small Cell Lung Cancer.1 passage
• The Effect of Systemic Chemotherapy on Survival in Patients With Localized, Regional, or Metastatic Adenocarcinoma of the Urinary Bladder.1 passage
• The Effect of Time to Postoperative Radiation Therapy on Survival in Resected Merkel Cell Carcinoma.1 passage
• The Efficacy of Adjuvant Chemotherapy in Patients With Stage II/III Resected Rectal Cancer Treated With Neoadjuvant Chemoradiation Therapy.1 passage
• The Efficacy of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer Harboring Wild-type Epidermal Growth Factor Receptor: A Meta-analysis of 25 RCTs.1 passage
• The Efficacy of Palonosetron Plus Dexamethasone in Preventing Chemoradiotherapy-induced Nausea and Emesis in Patients Receiving Daily Low-dose Cisplatin-based Concurrent Chemoradiotherapy for Uterine Cervical Cancer: A Phase II Study.1 passage
• The Evolving Role of Tumor Treating Fields in Managing Glioblastoma: Guide for Oncologists.1 passage
• The Frequency and Type of K-RAS Mutations in Mexican Patients With Colorectal Cancer: A National Study.1 passage
• The Impact of Body Mass Index on Freedom From Therapeutic Intervention and Quality of Life in Active Surveillance Prostate Cancer Patients.1 passage
• The Impact of COVID-19 on Patients With Cancer: A National Study of Patient Experiences.1 passage
• The Impact of Cancer on the Clinical Outcome of Patients After Inferior Vena Cava Filter Placement: A Retrospective Cohort Study.1 passage
• The Impact of Epidemiological Factors and Treatment Interventions on Survival in Patients With Signet Ring Cell Carcinoma of the Pancreas.1 passage
• The Impact of Perioperative Chemotherapy Timing in Conjunction With Postoperative External-Beam Radiation Therapy on Extremity Soft-Tissue Sarcomas Outcome.1 passage
• The Impact of Positive Margins on Outcome Among Patients With Gastric Cancer Treated With Radiation.1 passage
• The Impact of Radiotherapy Facility Volume on the Survival and Guideline Concordance of Patients With Muscle-invasive Bladder Cancer Receiving Bladder-preservation Therapy.1 passage
• The Impact of Serum Glucose in the Treatment of Locoregionally Advanced Pancreatic Cancer.1 passage
• The Impact of the COVID-19 Pandemic on Cancer Patients.1 passage
• The Influence of Age and Comorbidity on the Benefit of Adding Androgen Deprivation to Dose-escalated Radiation in Men With Intermediate-risk Prostate Cancer.1 passage
• The Integration of Multimodality Care for the Treatment of Small Cell Lung Cancer in a Rural Population and Its Impact on Survival.1 passage
• The Missing Pieces in Reporting of Randomized Controlled Trials of External Beam Radiation Therapy Dose Escalation for Prostate Cancer.1 passage
• The Natural History, Treatment Pattern, and Outcomes of Patients With Micropapillary Bladder Carcinoma.1 passage
• The Older Adults With Rectal Cancer-Does Age Matter?: A Single-center Experience.1 passage
• The Orphan Drug Act: Restoring the Mission to Rare Diseases.1 passage
• The Outcome of Patients With Localized Undifferentiated Pleomorphic Sarcoma of the Lower Extremity Treated at Stanford University.1 passage
• The Perceptions of Cancer Patients Regarding the Causes and Preventability of Unplanned Hospital Admissions.1 passage
• The Population-based Impact of Adjuvant Chemotherapy on Outcomes in T2N0M0 Non-Small Cell Lung Cancer.1 passage
• The Prognostic Role of Pretreatment Neutrophil to Lymphocyte Ratio (NLR) in Malignant Adrenal Lesions Treated With Stereotactic Body Radiation Therapy (SBRT).1 passage
• The Prognostic Significance of Facial Nerve Involvement in Carcinomas of the Parotid Gland.1 passage
• The Prognostic Significance of Pretreatment Hematologic Parameters in Patients Undergoing Resection for Colorectal Cancer.1 passage
• The Prognostic Significance of c-MET and EGFR Overexpression in Resected Gastric Adenocarcinomas.1 passage
• The Prospective Observational Cohort and the Nested Randomized Controlled Trial in the Pulmonary Metastasectomy in Colorectal Cancer (PulMiCC Study) Question the Reliance on Existing Evidence for the Magnitude of Benefit From Lung Metastasectomy.1 passage
• The Reliability of Intraoperative Assessment on Predicting Tumor Size, Myometrial Invasion, and Cervical Involvement in Patients With a Preoperative Diagnosis of Complex Atypical Hyperplasia or (Clinical Stage I) Endometrial Cancer: A Prospective Cohort Study.1 passage
• The Role of BCL-2 Proteins in the Development of Castration-resistant Prostate Cancer and Emerging Therapeutic Strategies.1 passage
• The Role of Definitive Radiotherapy in Craniopharyngioma: A SEER Analysis.1 passage
• The Role of Lymphadenectomy Versus Sentinel Lymph Node Biopsy in Early-stage Endometrial Cancer: A Review of the Literature.1 passage
• The Role of MRI in the Follow-up of Women Undergoing Breast-conserving Therapy.1 passage
• The Role of Partial Breast Radiation in the Previously Radiated Breast.1 passage
• The Role of Provider Characteristics in the Selection of Surgery or Radiation for Localized Prostate Cancer and Association With Quality of Care Indicators.1 passage
• The Role of Radiotherapy in Early-stage Primary Diffuse Large B-Cell Lymphoma of the Waldeyer Ring: A Retrospective Cohort Study.1 passage
• The Role of Radiotherapy in Resected R0/R+ Pancreatic Cancer: A Real-Life Single-Institution Experience.1 passage
• The Significance of Para-Aortic Nodal Size and the Role of Adjuvant Systemic Chemotherapy in Cervical Cancer: An Institutional Experience.1 passage
• The University of Florida Department of Radiation Oncology Guidelines for Treatment of Differentiated Thyroid Cancer With I-131 or External-beam Radiotherapy.1 passage
• The Utility of Diagnostic Laparoscopy in Patients Being Evaluated for Cytoreductive Surgery and Hyperthermic Peritoneal Chemotherapy.1 passage
• The Value of Prognostic Nutritional Index in Follicular Lymphoma.1 passage
• The association between tumor epidermal growth factor receptor (EGFR) mutation and multiple primary malignancies in patients with adenocarcinoma of the lungs.1 passage
• The effect of smoking and major vein resection on post-therapy lymphedema in soft tissue sarcomas treated with neoadjuvant radiation and limb-salvage surgery.1 passage
• The prognostic role of the preoperative absolute lymphocyte count and absolute monocyte count in patients with resected advanced melanoma.1 passage
• Third-line Salvage Chemotherapy for Recurrent Carcinoma of the Cervix is Associated With Minimal Response Rate and High Toxicity.1 passage
• Thyroid Paraganglioma: Our Experience and Systematic Review of the Literature on a Rare Tumor.1 passage
• Thyroid V50 Highly Predictive of Hypothyroidism in Head-and-Neck Cancer Patients Treated With Intensity-modulated Radiotherapy (IMRT).1 passage
• Time to Nadir PSA: Of Popes and PSA--The Immortality Bias.1 passage
• To What Extent Does Radiotherapy Improve the Quality of Life of Patients With Bone Metastasis?: A Prospective, Single-Institutional Study.1 passage
• Tobacco Treatment Programs at National Cancer Institute-designated Cancer Centers: A Systematic Review and Online Audit.1 passage
• Tolerability and Long-term Outcomes of Dose-Painted Neoadjuvant Chemoradiation to Regions of Vessel Involvement in Borderline or Locally Advanced Pancreatic Cancer.1 passage
• Total Lifetime and Cancer-related Costs for Elderly Patients Diagnosed With Anal Cancer in the United States.1 passage
• Totally Implantable Venous Access Devices: A Review of Complications and Management Strategies.1 passage
• Transformational Changes Between Non-Small Cell and Small Cell Lung Cancer-Biological and Clinical Relevance-A Review.1 passage
• Transperineal Template-guided Mapping Biopsy Identifies Pathologic Differences Between Very-Low-risk and Low-risk Prostate Cancer: Implications for Active Surveillance.1 passage
• Travel Distance as a Barrier to Receipt of Adjuvant Radiation Therapy After Radical Prostatectomy.1 passage
• Treating Locally Advanced Cervical Cancer With Concurrent Chemoradiation Without Brachytherapy in Low-resource Countries.1 passage
• Treating gynecologic malignancies in elderly patients.1 passage
• Treatment Modalities and Outcomes in Patients With Advanced Invasive Thymoma or Thymic Carcinoma: A Retrospective Multicenter Study.1 passage
• Treatment Outcomes in Very High-risk Prostate Cancer Treated by Dose-escalated and Combined-Modality Radiation Therapy.1 passage
• Treatment Patterns Among Women Diagnosed With Stage I-III Triple-negative Breast Cancer.1 passage
• Treatment Patterns and Survival of Elderly Patients With Breast Cancer Brain Metastases.1 passage
• Treatment Timing in Small Cell Lung Cancer, a National Cancer Database Analysis.1 passage
• Treatment Toxicity in Elderly Patients With Advanced Non-Small Cell Lung Cancer.1 passage
• Treatment and Outcomes of Primary Urethra Cancer.1 passage
• Treatment and Prevention of Brain Metastases in Small Cell Lung Cancer.1 passage
• Treatment of Small Cell Carcinoma of the Bladder With Chemotherapy and Radiation after Transurethral Resection of a Bladder Tumor.1 passage
• Treatment of cerebral radiation necrosis with bevacizumab: the Cleveland clinic experience.1 passage
• Treatment of chest wall sarcomas: a single-institution experience over 20 years.1 passage
• Treatment-related Hypertension as a Pharmacodynamic Biomarker for the Efficacy of Bevacizumab in Advanced Pancreas Cancer: A Pooled Analysis of 4 Prospective Trials of Gemcitabine-based Therapy With Bevacizumab.1 passage
• Trend in Age and Racial Disparities in the Receipt of Postlumpectomy Radiation Therapy for Stage I Breast Cancer: 2004-2009.1 passage
• Trends and Factors Associated With Receipt of Upfront Surgery for Stage II to III Rectal Adenocarcinoma in the United States, 2006 to 2016.1 passage
• Trends in Diagnosis and Treatment of Metastatic Cancer in the United States.1 passage
• Trends in Primary Surgical Resection and Chemotherapy for Metastatic Colorectal Cancer, 2000-2016.1 passage
• Trends in Radiation Dose and Technique For Anal Canal Squamous Cell Carcinoma.1 passage
• Trimodality Treatment of Malignant Pleural Mesothelioma: An Institutional Review.1 passage
• Tumor Deposits in Stage III Colon Cancer: Correlation With Other Histopathologic Variables, Prognostic Value, and Risk Stratification-Time to Consider "N2c".1 passage
• Tumor Growth Kinetics Before and After First-line Chemotherapy in Metastatic Castration-resistant Prostate Cancer: A Prostate-specific Antigen-based Retrospective Analysis.1 passage
• Tumor Necrotic Debris and High Nuclear Grade: Newly Identified High-risk Factors for Early-stage Endocervical Adenocarcinoma.1 passage
• Tumor Volume as Predictor of Pathologic Complete Response Following Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer.1 passage
• Tumor volume change with stereotactic body radiotherapy (SBRT) for early-stage lung cancer: evaluating the potential for adaptive SBRT.1 passage
• Twenty-five-Year Follow-up of a Prospective Randomized Trial Comparing Preoperative Versus Postoperative FLAC/Granulocyte Colony-Stimulating Factor Chemotherapy for Stage II Breast Cancer.1 passage
• Twitter: A Platform for Dissemination and Discussion of Scientific Papers in Radiation Oncology.1 passage
• Two-week Course of Preoperative Radiotherapy for Locally Advanced Rectal Adenocarcinoma: 8 Years' Experience in a Single Institute.1 passage
• Tyrosine Kinase Inhibitors and the Relationship With Adherence, Costs, and Health Care Utilization in Commercially Insured Patients With Newly Diagnosed Chronic Myeloid Leukemia: A Retrospective Claims-Based Study.1 passage
• Use of Hematopoietic Growth Factors in Elderly Lung Cancer Patients Receiving Chemotherapy: A SEER-Medicare-based Study.1 passage
• Use of Metabolic Parameters as Prognostic Factors During Concomitant Chemoradiotherapy for Locally Advanced Cervical Cancer.1 passage
• Use of Radiation Therapy in Locally Advanced Pancreatic Cancer Improves Survival: A SEER Database Analysis.1 passage
• Uterine Papillary Serous Carcinoma Arising in a Polyp: A Multicenter Retrospective Analysis on 75 Patients.1 passage
• Uterine and ovary carcinosarcomas: outcome, prognosis factors, and adjuvant therapy.1 passage
• Utility of the ACE Inhibitor Captopril in Mitigating Radiation-associated Pulmonary Toxicity in Lung Cancer: Results From NRG Oncology RTOG 0123.1 passage
• Utilization of Postoperative Chemoradiotherapy Among Women in the United States With High-risk Cervical Cancer.1 passage
• Utilization of an Alternative Docetaxel-based Intraperitoneal Chemotherapy Regimen in Patients With Ovarian, Fallopian Tube or Primary Peritoneal Carcinoma: A Continued Need for Ovarian Cancer Patients.1 passage
• Utilization of surgery, chemotherapy, radiation therapy, and hospice at the end of life for patients diagnosed with metastatic melanoma.1 passage
• Vaccination and Immune Checkpoint Inhibitors: Does Vaccination Increase the Risk of Immune-related Adverse Events? A Systematic Review of Literature.1 passage
• Vulvar Recurrences After Intensity-modulated Radiation Therapy for Squamous Cell Carcinoma of the Anus.1 passage
• Which Lymph Node Staging System Better Predicts Prognosis in Patients With Gastric Carcinoma? A Comparative Study Between 3 Different Lymph Node Classifications for Resected Gastric Cancer in a Western Tertiary Center.1 passage
• Whole Versus Partial Bladder Radiation: Use of an Image-guided Hypofractionated IMRT Bladder-preservation Protocol.1 passage
• Whole-Field Sequential Intensity-Modulated Radiotherapy for Local-Regional Advanced Head-and-Neck Squamous Cell Carcinoma.1 passage
• Wrong to be Right: Margin Laterality is an Independent Predictor of Biochemical Failure After Radical Prostatectomy.1 passage
• Yttrium-90 Microsphere Brachytherapy for Liver Metastases From Uveal Melanoma: Clinical Outcomes and the Predictive Value of Fluorodeoxyglucose Positron Emission Tomography.1 passage
• Yttrium-90 Radioembolization as Salvage Therapy for Liver Metastases From Colorectal Cancer.1 passage
• c-Met Overexpression in Cervical Cancer, a Prognostic Factor and a Potential Molecular Therapeutic Target.1 passage